LiveRamp (RAMP) 10-Q 6 Feb 15 2015 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Dec. 31, 2014	Feb. 03, 2015
Document and Entity Information
Entity Registrant Name	ACXIOM CORP
Entity Central Index Key	733269
Document Type	10-Q
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-28
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		77,276,038
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Mar. 31, 2014
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$126,891	$418,586
Trade accounts receivable, net	155,867	160,718
Deferred income taxes	15,809	12,870
Refundable income taxes	11,823	11,535
Restricted cash held in escrow	31,000
Other current assets	50,163	54,484
Assets from discontinued operations	478	7,332
Total current assets	392,031	665,525
Property and equipment, net of accumulated depreciation and amortization	216,488	216,906
Software, net of accumulated amortization	77,033	39,425
Goodwill	572,589	358,384
Purchased software licenses, net of accumulated amortization	14,555	18,584
Other assets, net	41,257	24,477
TOTAL ASSETS	1,313,953	1,323,301
Current liabilities:
Current installments of long-term debt	33,269	28,567
Trade accounts payable	33,527	36,179
Accrued expenses
Payroll	35,718	62,182
Other	69,338	70,412
Acquisition escrow payable	31,000
Deferred revenue	37,944	47,638
Income taxes payable		241
Liabilities from discontinued operations	1,548	4,250
Total current liabilities	242,344	249,469
Long-term debt	262,761	289,043
Deferred income taxes	103,498	90,226
Other liabilities	14,942	11,706
Equity:
Common stock	12,723	12,584
Additional paid-in capital	1,015,697	981,985
Retained earnings	597,837	602,829
Accumulated other comprehensive income	9,364	13,662
Treasury stock, at cost	-945,213	-928,203
Total equity	690,408	682,857
TOTAL LIABILITIES AND EQUITY	$1,313,953	$1,323,301

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenues	$260,440	$268,761	$762,692	$793,716
Operating costs and expenses:
Cost of revenue	203,728	201,430	601,349	596,642
Selling, general and administrative	47,345	43,383	144,766	123,857
Gains, losses and other items, net	4,175	4,657	12,556	11,241
Total operating costs and expenses	255,248	249,470	758,671	731,740
Income from operations	5,192	19,291	4,021	61,976
Other expense:
Interest expense	-2,610	-3,114	-7,576	-9,113
Other, net	-34	1,484	-562	1,238
Total other expense	-2,644	-1,630	-8,138	-7,875
Earnings (loss) from continuing operations before income taxes	2,548	17,661	-4,117	54,101
Income taxes	-1,926	3,083	-1,023	17,582
Net earnings (loss) from continuing operations	4,474	14,578	-3,094	36,519
Earnings (loss) from discontinued operations, net of tax	-318	489	-1,898	1,507
Net earnings (loss)	4,156	15,067	-4,992	38,026
Less: Net loss attributable to noncontrolling interest				-60
Net earnings (loss) attributable to Acxiom	$4,156	$15,067	($4,992)	$38,086
Basic earnings (loss) per share:
Net earnings (loss) from continuing operations (in dollars per share)	$0.06	$0.19	($0.04)	$0.49
Net earnings (loss) from discontinued operations (in dollars per share)		$0.01	($0.02)	$0.02
Basic (in dollars per share)	$0.05	$0.20	($0.06)	$0.51
Earnings (loss) per share attributable to Acxiom stockholders:
Basic (in dollars per share)	$0.05	$0.20	($0.06)	$0.51
Diluted earnings (loss) per share:
Net earnings (loss) from continuing operations (in dollars per share)	$0.06	$0.19	($0.04)	$0.48
Net earnings (loss) from discontinued operations (in dollars per share)		$0.01	($0.02)	$0.02
Diluted (in dollars per share)	$0.05	$0.19	($0.06)	$0.50
Earnings (loss) per share attributable to Acxiom stockholders:
Diluted (in dollars per share)	$0.05	$0.19	($0.06)	$0.50

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Net earnings (loss)	$4,156	$15,067	($4,992)	$38,026
Other comprehensive income (loss):
Change in foreign currency translation adjustment	-2,399	109	-4,293	1,022
Unrealized gain (loss) on interest rate swap	-93	334	-5	752
Other comprehensive income (loss)	-2,492	443	-4,298	1,774
Comprehensive income (loss)	1,664	15,510	-9,290	39,800
Less: comprehensive loss attributable to noncontrolling interests				-60
Comprehensive income (loss) attributable to Acxiom stockholders			($9,290)	$39,860

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENT OF EQUITY (USD $)	Common Stock	Additional paid-in Capital	Retained earnings	Accumulated other comprehensive income	Treasury Stock	Total
In Thousands, except Share data, unless otherwise specified
Balances at Mar. 31, 2014	$12,584	$981,985	$602,829	$13,662	($928,203)	$682,857
Balances (in shares) at Mar. 31, 2014					-49,203,507
Balances (in shares) at Mar. 31, 2014	125,843,608
Increase (Decrease) in Stockholders' Equity
Employee stock awards, benefit plans and other issuances	37	6,313			-7,157	-807
Employee stock awards, benefit plans and other issuances (in shares)	367,669				-367,172
Restricted stock units vested	101	-101
Restricted stock units vested (in shares)	1,005,967
Non-cash share-based compensation	1	20,522			15	20,538
Non-cash share-based compensation (in shares)	16,581
Acquisition of treasury stock					9,868	9,868
Acquisition of treasury stock (in shares)					-528,918	-500,000
LiveRamp replacement stock options		6,978				6,978
Comprehensive income (loss):
Foreign currency translation				-4,293		-4,293
Unrealized loss on interest rate swap				-5		-5
Net loss			-4,992			-4,992
Balances at Dec. 31, 2014	$12,723	$1,015,697	$597,837	$9,364	($945,213)	$690,408
Balances (in shares) at Dec. 31, 2014					-50,099,597
Balances (in shares) at Dec. 31, 2014	127,233,825

CONDENSED_CONSOLIDATED_STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net earnings (loss)	($4,992)	$38,026
Loss (earnings) from discontinued operations, net of tax	1,898	-1,507
Adjustments to reconcile net earnings (loss) to net cash from operating activities:
Depreciation and amortization	84,971	75,698
Gain on disposal or impairment of assets		-2,567
Loss on early extinguishment of debt		664
Deferred income taxes	-2,020	-3,666
Non-cash share-based compensation expense	20,538	10,344
Changes in operating assets and liabilities:
Accounts receivable, net	7,528	3,964
Other assets	3,483	6,932
Deferred costs	-1,488	-89
Accounts payable and other liabilities	-29,415	-11,756
Deferred revenue	-10,180	6,511
Net cash provided by operating activities	70,323	122,554
Cash flows from investing activities:
Capitalized software development costs	-14,985	-19,109
Capital expenditures	-51,529	-24,723
Data acquisition costs	-1,497	-4,660
Payments from investments		3,633
Net cash paid in acquisitions	-265,672
Net cash used in investing activities	-333,683	-44,859
Cash flows from financing activities:
Proceeds from debt		300,000
Payments of debt	-19,815	-230,167
Fees for debt refinancing		-4,370
Acquisition of noncontrolling interest		-600
Acquisition of treasury stock	-9,868	-52,663
Sale of common stock, net of stock acquired for withholding taxes	-807	69,106
Net cash provided by (used in) financing activities	-30,490	81,306
Net cash provided by (used in) continuing operations	-293,850	159,001
Cash flows from discontinued operations:
Net cash provided by (used in) operating activities	209	-1,412
Net cash provided by (used in) investing activities	2,927	-166
Net cash provided by (used in) discontinued operations	3,136	-1,578
Net cash provided by (used in) continuing and discontinued operations	-290,714	157,423
Effect of exchange rate changes on cash	-981	511
Net change in cash and cash equivalents	-291,695	157,934
Cash and cash equivalents at beginning of period	418,586	222,974
Cash and cash equivalents at end of period	126,891	380,908
Cash paid during the period for:
Interest	6,200	9,267
Income taxes	538	15,774
Payments on capital leases and installment payment arrangements	3,249	6,914
Other debt payments	16,566	8,253
Prepayments of debt		$215,000

BASIS_OF_PRESENTATION_AND_SUMM

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:	9 Months Ended
	Dec. 31, 2014
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
	1.             BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
	These condensed consolidated financial statements have been prepared by Acxiom Corporation (“Registrant,” “Acxiom” or “the Company”), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC” or “the Commission”).  In the opinion of the Registrant’s management all adjustments necessary for a fair presentation of the results for the periods included have been made and the disclosures are adequate to make the information presented not misleading.  All such adjustments are of a normal recurring nature.  Certain note information has been omitted because it has not changed significantly from that reflected in notes 1 through 18 of the Notes to Consolidated Financial Statements filed as part of Item 8 of the Registrant’s annual report on Form 10-K for the fiscal year ended March 31, 2014 (“2014 Annual Report”), as filed with the Commission on May 28, 2014.  This report and the accompanying condensed consolidated financial statements should be read in connection with the 2014 Annual Report.  The financial information contained in this report is not necessarily indicative of the results to be expected for any other period or for the full fiscal year ending March 31, 2015.
	On July 1, 2014, we completed our acquisition of LiveRamp, Inc. (“LiveRamp”). The results of LiveRamp are reflected in our condensed consolidated results as of the acquisition date (see note 5).
	Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States.  Actual results could differ from those estimates.  Certain of the accounting policies used in the preparation of these condensed consolidated financial statements are complex and require management to make judgments and/or significant estimates regarding amounts reported or disclosed in these financial statements.  Additionally, the application of certain of these accounting policies is governed by complex accounting principles and their interpretation.  A discussion of the Company’s significant accounting principles and their application is included in note 1 of the Notes to Consolidated Financial Statements and in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of the Company’s 2014 Annual Report.
	Reclassifications
	Certain amounts reported in previous periods have been reclassified to conform to the current presentation.  On May 30, 2014 the Company substantially completed the sale of its U.K. call center operation, 2Touch, to Parseq Ltd., a European business process outsourcing service provider.  Some assets of the 2Touch operation are subject to a second closing, expected to occur during the current fiscal year.  The 2Touch business qualified for treatment as discontinued operations during the current fiscal year.  The results of operations, cash flows, and the balance sheet amounts pertaining to 2Touch have been classified as discontinued operations in the condensed consolidated financial statements.  Refer to Note 4, Discontinued Operations, for more information regarding the sale.

EARNINGS_LOSS_PER_SHARE_AND_ST

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:	9 Months Ended
	Dec. 31, 2014
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:	2.             EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:
	Earnings (Loss) Per Share
	A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts):
		For the quarter ended						For the nine months ended
		December 31						December 31
		2014			2013			2014			2013
	Basic earnings (loss) per share:
	Net earnings (loss) from continuing operations	$	4,474		$	14,578		$	(3,094	)	$	36,519
	Net earnings (loss) from discontinued operations	(318		)	489			(1,898		)	1,507
	Net earnings (loss)	$	4,156		$	15,067		$	(4,992	)	$	38,026
	Net loss attributable to noncontrolling interest	—			—			—			(60		)
	Net earnings (loss) attributable to Acxiom	$	4,156		$	15,067		$	(4,992	)	$	38,086
	Basic weighted-average shares outstanding	77,039			75,009			76,998			74,155
	Basic earnings (loss) per share:
	Continuing operations	$	0.06		$	0.19		$	(0.04	)	$	0.49
	Discontinued operations	$	—		$	0.01		$	(0.02	)	$	0.02
	Net earnings (loss)	$	0.05		$	0.2		$	(0.06	)	$	0.51
	Net loss attributable to noncontrolling interest	$	—		$	—		$	—		$	—
	Net earnings (loss) attributable to Acxiom	$	0.05		$	0.2		$	(0.06	)	$	0.51
	Diluted earnings (loss) per share:
	Basic weighted-average shares outstanding	77,039			75,009			76,998			74,155
	Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method	1,263			2,830			—			2,301
	Diluted weighted-average shares outstanding	78,302			77,839			76,998			76,456
	Diluted earnings (loss) per share:
	Continuing operations	$	0.06		$	0.19		$	(0.04	)	$	0.48
	Discontinued operations	$	—		$	0.01		$	(0.02	)	$	0.02
	Net earnings (loss)	$	0.05		$	0.19		$	(0.06	)	$	0.5
	Net earnings (loss) attributable to noncontrolling interest	$	—		$	—		$	—		$	—
	Net earnings (loss) attributable to Acxiom	$	0.05		$	0.19		$	(0.06	)	$	0.5
	Some earnings (loss) per share amounts may not add due to rounding.
	Options and warrants to purchase shares of common stock and restricted stock units that were outstanding during the periods presented, but were not included in the computation of diluted earnings (loss) per share because the effect was antidilutive are shown below (in thousands, except per share amounts):
		For the quarter ended				For the nine months ended
		December 31				December 31
		2014		2013		2014		2013
	Number of shares outstanding under options, warrants and restricted stock units	2,012		549		1,838		1,400
	Range of exercise prices for options and warrants	$18.78-$62.06		$32.85-$62.06		$19.18-$62.06		$21.46-$62.06
	In addition to the antidilutive items shown above, because of the loss reported for the nine months ended December 31, 2014, all options, warrants, and restricted stock are excluded from the diluted weighted-average shares calculation for that period since the effect would be antidilutive.
	Stockholders’ Equity
	On August 29, 2011, the board of directors adopted a common stock repurchase program.  That program was subsequently modified and expanded on December 5, 2011, on May 24, 2012, on February 5, 2013, on November 18, 2013, and again on November 12, 2014.  Under the modified common stock repurchase program, the Company may purchase up to $250.0 million of its common stock through the period ending November 12, 2015. During the nine months ended December 31, 2014, the Company repurchased 0.5 million shares of its common stock for $9.9 million.  Through December 31, 2014, the Company had repurchased 12.9 million shares of its stock for $202.4 million, leaving remaining capacity of $47.6 million under the stock repurchase program.
	Accumulated Other Comprehensive Income
	The accumulated balances for each component of other comprehensive income are as follows (dollars in thousands):
		December 31,			March 31,
		2014			2014
	Foreign currency translation	$	9,393		$	13,686
	Unrealized loss on interest rate swap	(29		)	(24		)
		$	9,364		$	13,662
	Noncontrolling Interest
	During fiscal year 2011, the Company acquired a 70% interest in GoDigital (Acxiom Brazil), a data quality and precision marketing firm located in Brazil.  Since Acxiom had voting control of the entity, its results were included in Acxiom’s consolidated results.  The interest that was not Acxiom-owned was reflected as noncontrolling interest in the condensed consolidated statement of operations and the condensed consolidated balance sheets.  During fiscal 2014, the Company acquired the balance of the outstanding equity interests it did not already own in Acxiom Brazil and, as a result, the subsidiary is now wholly-owned.

SHAREBASED_COMPENSATION

SHARE-BASED COMPENSATION:	9 Months Ended
	Dec. 31, 2014
SHARE-BASED COMPENSATION:
SHARE-BASED COMPENSATION:	3.             SHARE-BASED COMPENSATION:
	Share-based Compensation Plans
	The Company has stock option and equity compensation plans for which a total of 26.4 million shares of the Company’s common stock have been reserved for issuance since inception of the plans.  These plans provide that the exercise prices of qualified options will be at or above the fair market value of the common stock at the time of the grant.  Board policy requires that nonqualified options also be priced at or above the fair market value of the common stock at the time of grant.  At December 31, 2014, there were a total of 2.6 million shares available for future grants under the plans.
	Stock Option Activity
	The Company granted 415,639 stock options in the nine months ended December 31, 2014, exclusive of replacement options granted in connection with the LiveRamp acquisition.  The per-share weighted-average fair value of the stock options granted during the nine months ended December 31, 2014 was $8.05.  This valuation was determined using a customized binomial lattice approach with the following weighted-average assumptions: dividend yield of 0.0%; risk-free interest rate of 2.5%; expected option life of 4.4 years; expected volatility of 43% and a suboptimal exercise multiple of 1.4.  The dividend yield was determined to be 0.0% since Acxiom is currently not paying dividends and there are no plans to pay dividends.  The risk-free rate was determined by reference to the U.S. Treasury securities with a term equal to the life of the options.  The expected option life is an output of the lattice model.  The expected volatility was determined by considering both the historical volatility of Acxiom stock, as well as the implied volatility of traded Acxiom options.  The suboptimal exercise multiple was determined using actual historical exercise activity of Acxiom options.
	As part of the Company’s acquisition of LiveRamp, the Company issued replacement stock options to LiveRamp employees who had outstanding unvested stock options to purchase LiveRamp stock.  The fair value of the replacement options was determined using a customized binomial lattice model with the following assumptions:  dividend yield of 0.0% since Acxiom does not currently pay dividends; risk-free interest rates of from 1.57% to 2.54%, based on the rate of U.S. Treasury securities with a term equal to the remaining term of each option; remaining terms of each option of from 6.1 to 9.7 years; expected volatility of 43%, based on both the historical volatility of Acxiom stock, as well as the implied volatility of traded Acxiom options; and a suboptimal exercise multiple of 1.4, based on actual historical exercise activity of Acxiom options.
	The number of shares of each replacement option and the exercise price of each replacement option was determined by converting LiveRamp options into equivalent Acxiom options by multiplying the number of shares subject to LiveRamp options by the exchange ratio of .63774 and by dividing the exercise price for each LiveRamp option by the exchange ratio of .63774.  Once the value of each replacement option was determined, the percentage of that value which was attributed to employee service prior to the acquisition date was allocated to the purchase price of LiveRamp, and the remaining value will be expensed by the Company over the remaining vesting period of each option.  The total included in the purchase price was $7.0 million (see note 5) and the total to be expensed in the future was $23.5 million.
	Option activity for the nine months ended December 31, 2014 was as follows:
		Number		Weighted-average			Weighted-average	Aggregate
		of shares		exercise price			remaining	intrinsic value
				per share			contractual term	(in thousands)
							(in years)
	Outstanding at March 31, 2014	4,538,518		$	20.3
	Granted	415,639		$	21.01
	LiveRamp replacement stock options	1,473,668		$	1.37
	Exercised	(91,200	)	$	6.05			$	1,312
	Forfeited or cancelled	(652,262	)	$	30.54
	Outstanding at December 31, 2014	5,684,363		$	14.49		5.14	$	41,046
	Exercisable at December 31, 2014	3,387,728		$	17.74		3.22	$	15,994
	The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between Acxiom’s closing stock price on the last trading day of the quarter and the exercise price for each in-the-money option) that would have been realized by the option holders had option holders exercised their options on December 31, 2014.  This amount changes based upon changes in the fair market value of Acxiom’s common stock.
	Following is a summary of stock options outstanding and exercisable as of December 31, 2014:
		Options outstanding						Options exercisable
	Range of	Options		Weighted- average		Weighted-average		Options		Weighted-average
	exercise price	outstanding		remaining		exercise price		exercisable		exercise price
	per share			contractual life		per share				per share
	$   0.63 - $   8.90	1,411,953		7.54 years		$	1.56	272,262		$	2.09
	$  11.08 - $ 14.42	1,715,499		5.52 years		$	13.22	1,192,268		$	13.10
	$  15.10 - $ 19.76	651,390		2.31 years		$	16.38	617,260		$	16.23
	$  20.44 - $ 25.00	1,571,693		4.61 years		$	22.33	986,775		$	22.95
	$  26.33 - $ 35.16	203,007		1.32 years		$	30.86	188,342		$	30.71
	$  41.38 - $ 62.06	130,821		0.64 years		$	41.83	130,821		$	41.83
		5,684,363		5.14 years		$	14.49	3,387,728		$	17.74
	Total expense related to stock options for the nine months ended December 31, 2014 and 2013 was approximately $7.0 million and $1.7 million respectively.  Future expense for these options is expected to be approximately $23.7 million over the next four years.
	Stock Appreciation Right (SAR) Activity
	During the nine months ended December 31, 2014, the Company granted 245,404 performance-based SARs with a value at the date of grant of $0.5 million and having an exercise price of $40.  All of the performance-based SARs granted in the current period vest subject to attainment of performance criteria established by the compensation committee of the board of directors.  The units granted in the current period may vest in a number of SARs up to 100% of the award, based on the attainment of certain revenue targets for the period from April 1, 2014 to March 31, 2017.  At vesting, the SARs will be automatically exercised, and the award recipient may receive a number of common stock shares equal to the number of SARs that are being exercised multiplied by the quotient of (a) the final Company stock market value (up to a maximum share value of $70) minus the SAR exercise price, divided by (b) the SAR exercise price.  The SARs contain an accelerated exercise provision if the closing market price of the Company’s stock exceeds the $70 maximum share value for 20 consecutive trading days during the performance period.   The grant date value of the performance-based SARs is determined using a Monte Carlo simulation model.
	Following is a summary of SAR activity for the nine months ended December 31, 2014:
		Number		Weighted-average			Weighted-average	Aggregate
		of shares		exercise price			remaining	intrinsic value
				per share			contractual term	(in thousands)
							(in years)
	Outstanding at March 31, 2014	—		$	—
	Granted	245,404		$	40.00
	Outstanding at December 31, 2014	245,404		$	40.00		2.25	$	—
	Exercisable at December 31, 2014	—		$	—		—	$	—
	Total expense related to SARs for the nine months ended December 31, 2014 was $0.1 million.  Future expense for these SARs is expected to be approximately $0.4 million over the next three years.
	Restricted Stock Unit Activity
	During the nine months ended December 31, 2014, the Company granted time-vesting restricted stock units covering 1,650,662 shares of common stock with a value at the date of grant of $35.4 million, of which units covering 1,075,392 shares, with a value at date of grant of $23.7 million, were granted to former LiveRamp employees subsequent to the acquisition of LiveRamp (see note 5).  Of the restricted stock units granted in the current period, 673,482 vest in equal annual increments over four years, 928,252 vest in equal annual increments over two years, and 48,928 vest in one year.  Valuation of these units is equal to the quoted market price for the shares on the date of grant.
	Non-vested time-vesting restricted stock unit activity for the nine-month period ending December 31, 2014 was as follows:
		Number		Weighted average			Weighted-average
		of shares		fair value per			remaining contractual
				share at grant			term (in years)
				date
	Outstanding at March 31, 2014	1,078,029		$	18.46		2.17
	Granted	1,650,662		$	21.43
	Vested	(404,428	)	$	17.94
	Forfeited or cancelled	(207,608	)	$	22.02
	Outstanding at December 31, 2014	2,116,655		$	21.59		2.21
	During the nine months ended December 31, 2014, the Company granted performance-based restricted stock units covering 259,167 shares of common stock with a value at the date of grant of $4.9 million.  All of the performance-based restricted stock units granted in the current period vest subject to attainment of performance criteria established by the compensation committee of the board of directors.  The units granted in the current period may vest in a number of shares from zero to 200% of the award, based on the attainment of an earnings-per-share target for fiscal 2017, with a modifier based on the total shareholder return of Acxiom stock compared to total shareholder return of a group of peer companies established by the compensation committee of the board of directors for the period from April 1, 2014 to March 31, 2017.  The value of the performance units is determined using a Monte Carlo simulation model.
	Non-vested performance-based restricted stock unit activity for the nine-month period ending December 31, 2014 was as follows:
		Number		Weighted average			Weighted-average
		of shares		fair value per			remaining contractual
				share at grant			term (in years)
				date
	Outstanding at March 31, 2014	1,066,828		$	14.19		0.91
Granted	259,167		$	18.98
Vested	(523,378	)	$	9.64
Forfeited or cancelled	(43,864	)	$	24.87
Outstanding at December 31, 2014	758,753		$	18.57		1.41
Total expense related to all restricted stock units in the nine months ended December 31, 2014 and 2013 was approximately $12.8 million and $8.6 million respectively.  Future expense for these restricted stock units is expected to be approximately $39.5 million over the next four years.
Other Performance Unit Activity
During the nine months ended December 31, 2014, the Company granted 201,464 performance-based units with a value at the date of grant of $1.0 million.  All of the performance-based units granted in the current period vest subject to attainment of performance criteria established by the compensation committee of the board of directors.  The units granted in the current period may vest in a number of units up to 100% of the award, based on the attainment of certain revenue targets for the period from April 1, 2014 to March 31, 2017.  At vesting, the award recipient may receive a number of common stock shares equal to the number of units vested multiplied by a share price factor.  The share price factor modifies the final number of common shares awarded based on the Company’s stock price on the date of vesting and ranges from 0% at a $40 Company stock price, or below, to 100% at a $70 Company stock price. The units also contain an accelerated exercise provision if the closing market price of the Company’s stock exceeds the $70 maximum share value for 20 consecutive trading days during the performance period.   The grant date value of the performance-based units is determined using a Monte Carlo simulation model.
Following is a summary of other performance unit activity for the nine months ended December 31, 2014:
	Number		Weighted average			Weighted-average
	of shares		fair value per			remaining contractual
			share at grant			term (in years)
			date
Outstanding at March 31, 2014	—		$	—
Granted	201,464		$	5.18
Outstanding at December 31, 2014	201,464		$	5.18		2.25
Total expense related to other performance units for the nine months ended December 31, 2014 was $0.2 million.  Future expense for these performance units is expected to be approximately $0.8 million over the next three years.

DISCONTINUED_OPERATIONS

DISCONTINUED OPERATIONS	9 Months Ended
	Dec. 31, 2014
DISCONTINUED OPERATIONS:
DISCONTINUED OPERATIONS	4.             DISCONTINUED OPERATIONS:
	On May 30, 2014, the Company substantially completed the sale of its U.K. call center operation, 2Touch, to Parseq Ltd., a European business process outsourcing service provider.  Some assets of the 2Touch operation are subject to a second closing, expected to occur during the current fiscal year.  The 2Touch business qualified for treatment as discontinued operations during the current fiscal year.  The results of operations, cash flows, and the balance sheet amounts pertaining to 2Touch have been classified as discontinued operations in the condensed consolidated financial statements.
	Prior to receiving the discontinued operations classification, the 2Touch business unit was included in the Other services segment in the Company’s segment results.  However, beginning in the first quarter of the current fiscal year, the 2Touch business unit was excluded from segment results and segregated as discontinued operations.
	Summary results of operations of the 2Touch business unit for the three and nine months ended December 31, 2014 and 2013, respectively, are segregated and included in earnings (loss) from discontinued operations, net of tax, in the condensed consolidated statements of operations and are as follows (dollars in thousands):
		For the quarter ended					For the nine months ended
		December 31					December 31
		2014			2013		2014			2013
	Revenues	$	1,250		$	9,112	$	8,490		$	26,621
	Earnings (loss) from discontinued operations before income taxes	$	(318	)	$	489	$	(23	)	$	1,507
	Loss on sale of discontinued operations before income taxes	—			—		(1,875		)	—
	Income taxes	—			—		—			—
	Earnings (loss) from discontinued operations, net of tax	$	(318	)	$	489	$	(1,898	)	$	1,507
	The carrying amounts of the major classes of assets and liabilities of the 2Touch business unit are segregated and included in assets from discontinued operations and liabilities from discontinued operations in the condensed consolidated balance sheets and are as follows (dollars in thousands):
		December 31,			March 31,
		2014			2014
	Trade accounts receivable, net	$	478		$	6,451
	Other current assets	—			881
	Assets from discontinued operations	$	478		$	7,332
	Trade accounts payable and accrued expenses	$	—		$	4
	Accrued payroll and related expenses	279			1,790
	Other accrued expenses	1,170			2,350
	Deferred revenue	99			106
	Liabilities from discontinued operations	$	1,548		$	4,250

ACQUISITIONS

ACQUISITIONS:	9 Months Ended
	Dec. 31, 2014
ACQUISITIONS:
ACQUISITIONS:	5.             ACQUISITIONS
	On July 1, 2014, the Company acquired all of the outstanding shares of LiveRamp, Inc. (“LiveRamp”), a leading service provider for onboarding customer data into digital marketing applications.  As a result of this transaction, LiveRamp is now a wholly-owned subsidiary of the Company.  The Company acquired LiveRamp to, among other things, provide clients with solutions for bringing offline customer data online with better matching, more connectivity, and faster onboarding.  The Company has included the financial results of LiveRamp in the condensed consolidated financial statements from the date of acquisition.  LiveRamp is included in the Marketing and data services segment.  The acquisition date fair value of the consideration transferred for LiveRamp was approximately $272.7 million which consisted of the following (dollars in thousands):
		July 1, 2014
	Cash, net of $12.0 million cash acquired	$	234,672
	Restricted cash held in escrow	31,000
	Fair value of stock options issued included in purchase price	6,978
	Total fair value of consideration transferred	$	272,650
	The fair value of the stock options issued by the Company was determined using a binomial lattice approach (see note 3).  The total fair value of the stock options issued was $30.5 million of which $7.0 million was allocated to the purchase consideration and $23.5 million was allocated to future services and will be expensed over the remaining service periods on a straight-line basis.
	On the acquisition date, the Company delivered $31.0 million of cash to an escrow agent according to the terms of the purchase agreement.  The cash is restricted as to withdrawal or use by the Company and is expected to be delivered to the LiveRamp sellers one year from the acquisition date.  The escrowed cash can be used to reimburse the Company for any indemnification claims against the sellers, as described in the purchase agreement.  The principal escrow amount is owned by the Company until funds are delivered to the LiveRamp sellers.  All interest and earnings on the principal escrow amount remain property of the Company.  The restricted cash is reported as restricted cash held in escrow, with an offsetting liability reported as acquisition escrow payable, on the condensed consolidated balance sheet.
	The following table summarizes the estimated fair values of assets acquired and liabilities assumed as of the date of the acquisition (dollars in thousands):
		July 1, 2014
	Assets acquired:
	Cash	$	12,016
	Trade accounts receivable	5,206
	Deferred income tax assets	10,444
	Goodwill	215,967
	Developed technology (Software)	40,000
	Other intangible assets (Other assets, net)	26,500
	Other current and noncurrent assets	1,307
		311,440
	Deferred income tax liabilities	(21,820		)
	Accounts payable, accrued expenses and deferred revenue	(4,954		)
	Net assets acquired	284,666
	Less:
	Cash acquired	12,016
	Net purchase price allocated	$	272,650
	Less:
	Fair value of stock options issued included in purchase price	6,978
	Net cash paid	$	265,672
	The excess of purchase consideration over the fair value of net tangible and identifiable intangible assets acquired was recorded as goodwill and is primarily attributed to expectations to continue to develop future technology and products related to the onboarding of customer data into digital marketing applications, development of future customer relationships, and LiveRamp’s assembled workforce.  The fair values assigned to tangible and identifiable intangible assets acquired and liabilities assumed were based on preliminary calculations and valuations and on management’s estimates and assumptions and were based on the information that was available as of the date of the acquisition.  The Company believes that the information provides a reasonable basis for estimating the fair values of assets acquired and liabilities assumed, but certain items such as current and noncurrent income taxes payable and deferred taxes may be subject to change as additional information is received and certain tax returns are finalized.  Therefore, the provisional measurements of fair value shown above are subject to change.  Any adjustments required will result in adjustment to goodwill.  The Company expects to finalize the valuation as soon as practicable, but not later than the end of the current fiscal year.  The goodwill balance is not deductible for U.S. income tax purposes.
	The fair value of trade accounts receivable was comprised of $5.2 million of gross accounts receivable, of which an immaterial amount is expected to be uncollectible.  The amounts allocated to other intangible assets in the table above included developed technology, customer relationships, and a trade name.  Intangible assets will be amortized on a straight-line basis over the estimated useful lives of 2 to 6 years. The following table presents the components of intangible assets acquired and their estimated useful lives as of the acquisition date (dollars in thousands):
		Fair value			Useful life
					(in years)
	Developed technology	$	40,000		4
	Customer relationship	25,000			6
	Trade name	1,500			2
	Total intangible assets subject to amortization	$	66,500
	The amounts of revenue and loss of LiveRamp included in the Company’s condensed consolidated statement of operations from the acquisition date of July 1, 2014 to December 31, 2014 are as follows (dollars in thousands):
	Revenues	$	15,916
	Net loss	$	(10,022	)
	The $10.0 million net loss reported above includes pretax expenses of $7.5 million of intangible asset amortization associated with acquired LiveRamp intangible assets and $9.9 million of non-cash share-based compensation expense.
	Following are the Company’s supplemental consolidated results on an unaudited pro forma basis, as if the LiveRamp acquisition had taken place at the beginning of each of the fiscal years presented (dollars in thousands):
		For the quarter ended					For the nine months ended
		December 31					December 31
		2014			2013		2014			2013
	Revenues	$	260,440		$	274,276	$	769,400		$	807,156
	Net earnings (loss) attributable to Acxiom	$	4,156		$	10,263	$	(10,363	)	$	23,102
	Diluted earnings per share	$	0.05		$	0.13	$	(0.13	)	$	0.3
	These pro forma results are based on estimates and assumptions, which we believe are reasonable.  They are not the results that would have been realized had we been a combined company during the periods presented and are not necessarily indicative of our consolidated results of operations in future periods.  The pro forma results include adjustments primarily related to purchase accounting adjustments, including amortization expense of $3.7 million per quarter related to acquired intangible assets, stock-based compensation expense of approximately $4.8 million per quarter related to unvested stock options and restricted stock units issued to former LiveRamp employees, and the related income tax effects as though the acquisition occurred as of the beginning of the Company’s fiscal years 2014 and 2015.
	During the nine months ended December 31, 2014, the Company incurred $0.8 million of acquisition costs related to the purchase of LiveRamp.  The costs are included in gains, losses, and other items, net on the condensed consolidated statement of operations.

OTHER_CURRENT_AND_NONCURRENT_A

OTHER CURRENT AND NONCURRENT ASSETS:	9 Months Ended
	Dec. 31, 2014
OTHER CURRENT AND NONCURRENT ASSETS:
OTHER CURRENT AND NONCURRENT ASSETS:	6.             OTHER CURRENT AND NONCURRENT ASSETS:
	Other current assets consist of the following (dollars in thousands):
		December 31,		March 31,
		2014		2014
	Prepaid expenses	$	35,745	$	40,339
	Assets of non-qualified retirement plan	14,174		13,900
	Other miscellaneous assets	244		245
	Other current assets	$	50,163	$	54,484
	Other noncurrent assets consist of the following (dollars in thousands):
		December 31,		March 31,
		2014		2014
	Acquired intangible assets, net	$	24,164	$	281
	Deferred data acquisition costs	3,211		4,502
	Deferred expenses	10,291		16,143
	Other miscellaneous noncurrent assets	3,591		3,551
	Noncurrent assets	$	41,257	$	24,477
	The acquired intangible assets noted above represent customer relationship and trade name intangibles acquired through purchase acquisitions, net of accumulated amortization, of which $24.0 million at December 31, 2014 relates to the LiveRamp acquisition in the current fiscal year (see note 5).

GOODWILL

GOODWILL:	9 Months Ended
	Dec. 31, 2014
GOODWILL:
GOODWILL:	7.             GOODWILL:
	Goodwill is measured and tested for impairment on an annual basis in the first quarter of the Company’s fiscal year in accordance with applicable accounting standards, or more frequently if indicators of impairment exist.  Triggering events for interim impairment testing include indicators such as adverse industry or economic trends, restructuring actions, downward revisions to projections of financial performance, or a sustained decline in market capitalization.  The performance of the impairment test involves a two-step process.  The first step requires comparing the estimated fair value of a reporting unit to its net book value, including goodwill.  A potential impairment exists if the estimated fair value of the reporting unit is lower than its net book value.  The second step of the impairment test involves assigning the estimated fair value of the reporting unit to its identifiable assets, with any residual fair value being assigned to goodwill.  If the carrying value of an individual indefinite-lived intangible asset (including goodwill) exceeds its estimated fair value, such asset is written down by an amount equal to the excess, and a corresponding amount is recorded as a charge to operations for the period in which the impairment test is completed.  Completion of the Company’s annual impairment test during the quarter ended June 30, 2014 indicated no potential impairment of its goodwill balances.
	The carrying amount of goodwill, by operating segment, at December 31, 2014, and the changes in those balances are presented in the following table.
	(dollars in thousands)	Marketing and			IT		Total
		Data Services			Infrastructure
					Management
	Balance at March 31, 2014	$	286,876		$	71,508	$	358,384
	LiveRamp acquisition	215,967			—		215,967
	Change in foreign currency translation adjustment	(1,762		)	—		(1,762		)
	Balance at December 31, 2014	$	501,081		$	71,508	$	572,589
	Goodwill by component included in the Marketing and data services segment as of December 31, 2014 is U.S., $482.7 million; Australia, $11.6 million; China, $6.0 million; and Brazil, $0.8 million.  Goodwill from the LiveRamp acquisition is included in the U.S. component.
	In order to estimate the fair value for each of the components, management uses an income approach based on a discounted cash flow model together with valuations based on an analysis of public company market multiples and a similar transactions analysis.
	The key assumptions used in the discounted cash flow valuation model include discount rates, growth rates, cash flow projections and terminal value rates. Discount rates, growth rates and cash flow projections are the most sensitive and susceptible to change as they require significant management judgment. Discount rates are determined by using a weighted average cost of capital (“WACC”). The WACC considers market and industry data as well as company-specific risk factors for each reporting unit in determining the appropriate discount rate to be used. The discount rate utilized for each reporting unit is indicative of the return an investor would expect to receive for investing in such a business. Management, considering industry and company-specific historical and projected data, develops growth rates and cash flow projections for each reporting unit. Terminal value rate determination follows common methodology of capturing the present value of perpetual cash flow estimates beyond the last projected period assuming a constant WACC and low long-term growth rates.
	The public company market multiple method is used to estimate values for each of the components by looking at market value multiples to revenue and EBITDA (earnings before interest, taxes, depreciation and amortization) for selected public companies that are believed to be representative of companies that marketplace participants would use to arrive at comparable multiples for the individual component being tested.  These multiples are then used to develop an estimated value for each respective component.
	The similar transactions method compares multiples based on acquisition prices of other companies believed to be those that marketplace participants would use to compare to the individual component being tested.  Those multiples are then used to develop an estimated value for that component.
	In order to arrive at an estimated value for each component, management uses a weighted-average approach to combine the results of each analysis.  Management believes that using multiple valuation approaches and then weighting them appropriately is a technique that a marketplace participant would use.
	As a final test of the annual valuation results, the total of the values of the components is reconciled to the actual market value of Acxiom common stock as of the valuation date.  Management believes the resulting control premium is reasonable compared to historical control premiums observed in actual transactions.
	Goodwill is tested for impairment at the reporting unit level, which is defined as either an operating segment or one step below an operating segment, known as a component.  At April 1, 2014, Acxiom’s segments were the Marketing and data services segment and the IT Infrastructure management segment.  Because the Marketing and data services segment contains both U.S. and International components, and there are differences in economic characteristics between the components in the different geographic regions, management tested a total of five components at the beginning of the year.  The goodwill amounts as of April 1, 2014 included in each component tested were:  U.S. Marketing and data services, $266.7 million; Australia Marketing and data services, $13.3 million; China Marketing and data services, $6.0 million; Brazil Marketing and data services, $0.9 million; and U.S. IT Infrastructure management, $71.5 million.
	As of April 1, 2014, each of the components had an estimated fair value in excess of its carrying value, indicating no impairment.  All of the components had an excess fair value exceeding 35%, except for U.S. IT Infrastructure management.  The fair value of the U.S. IT Infrastructure management segment has decreased by a significant amount since the prior annual test as a result of client contract terminations.  If the U.S. IT Infrastructure management segment experiences additional client losses in the future, this could lead to a further deterioration in value, which could lead to an impairment in the future.
	Management believes that the estimated valuations it arrived at are reasonable and consistent with what other marketplace participants would use in valuing the Company’s components.  However, management cannot give any assurance that these market values will not change in the future.  For example, if discount rates demanded by the market increase, this could lead to reduced valuations under the income approach.  If the Company’s projections are not achieved in the future, this could lead management to reassess their assumptions and lead to reduced valuations under the income approach.  If the market price of the Company’s stock decreases, this could cause the Company to reassess the reasonableness of the implied control premium, which might cause management to assume a higher discount rate under the income approach which could lead to reduced valuations.  If future similar transactions exhibit lower multiples than those observed in the past, this could lead to reduced valuations under the similar transactions approach.  And finally, if there is a general decline in the stock market and particularly in those companies selected as comparable to the Company’s components, this could lead to reduced valuations under the public company market multiple approach.  The Company’s next annual impairment test will be performed during the first quarter of fiscal 2016.  The fair value of the Company’s components could deteriorate which could result in the need to record impairment charges in future periods.  The Company continues to monitor potential triggering events including changes in the business climate in which it operates, attrition of key personnel, the volatility in the capital markets, the Company’s market capitalization compared to its book value, the Company’s recent operating performance, and the Company’s financial projections.  The occurrence of one or more triggering events could require additional impairment testing, which could result in impairment charges.

LONGTERM_DEBT

LONG-TERM DEBT:	9 Months Ended
	Dec. 31, 2014
LONG-TERM DEBT:
LONG-TERM DEBT:	8.             LONG-TERM DEBT:
	Long-term debt consists of the following (dollars in thousands):
		December 31,		March 31,
		2014		2014
	Term loan credit agreement	$	277,500	$	292,500
	Capital leases and installment payment obligations on land, buildings and equipment payable in monthly payments of principal plus interest at rates ranging from approximately 4% to 8%; remaining terms up to eight years	7,975		12,990
	Other debt and long-term liabilities	10,555		12,120
	Total long-term debt and capital leases	296,030		317,610
	Less current installments	33,269		28,567
	Long-term debt, excluding current installments	$	262,761	$	289,043
	The Company’s amended and restated credit agreement provides for (1) term loans up to an aggregate principal amount of $300 million and (2) revolving credit facility borrowings consisting of revolving loans, letter of credit participations and swing-line loans up to an aggregate amount of $300 million.
	The term loan agreement is payable in quarterly installments of $7.5 million through September 2017, followed by quarterly installments of $11.3 million through June 2018, with a final payment of $161.3 million due October 9, 2018.  The revolving loan commitment expires October 9, 2018.
	Term loan and revolving credit facility borrowings bear interest at LIBOR or at an alternative base rate plus a credit spread.  At December 31, 2014, the LIBOR credit spread was 2.00%.  There were no revolving credit borrowings outstanding at December 31, 2014 or March 31, 2014.  The weighted-average interest rate on term loan borrowings at December 31, 2014 was 2.3%.  Outstanding letters of credit at December 31, 2014 were $2.2 million.
	The term loan allows for prepayments before maturity.  The credit agreement is secured by the accounts receivable of Acxiom and its domestic subsidiaries, as well as by the outstanding stock of certain Acxiom subsidiaries.
	Under the terms of the term loan, the Company is required to maintain certain debt-to-cash flow and debt service coverage ratios, among other restrictions.  At December 31, 2014, the Company was in compliance with these covenants and restrictions.  In addition, if certain financial ratios and other conditions are not satisfied, the revolving credit facility limits the Company’s ability to pay dividends in excess of $30 million in any fiscal year (plus additional amounts in certain circumstances).
	On March 10, 2014, the Company entered into an interest rate swap agreement.  The agreement provides for the Company to pay interest through March 10, 2017 at a fixed rate of 0.98% plus the applicable credit spread on $50.0 million notional amount, while receiving interest for the same period at the LIBOR rate on the same notional amount.  The LIBOR rate as of December 31, 2014 was 0.25%.  The swap was entered into as a cash flow hedge against LIBOR interest rate movements on the term loan.  The Company assesses the effectiveness of the hedge based on the hypothetical derivative method.  There was no ineffectiveness for the period ended December 31, 2014.  Under the hypothetical derivative method, the cumulative change in fair value of the actual swap is compared to the cumulative change in fair value of the hypothetical swap, which has terms that identically match the critical terms of the hedged transaction.  Thus, the hypothetical swap is presumed to perfectly offset the hedged cash flows.  The change in the fair value of the hypothetical swap will then be regarded as a proxy for the present value of the cumulative change in the expected future cash flows from the hedged transactions.  All of the fair values are derived from an interest-rate futures model.  As of December 31, 2014, the hedge relationship still qualified as an effective hedge under applicable accounting standards.  Consequently, all changes in fair value of the derivative will be deferred and recorded in other comprehensive income (loss) until the related forecasted transaction is recognized in the condensed consolidated statement of operations.  The fair market value of the derivative was zero at inception and an unrealized loss of $0.03 million since inception is recorded in other comprehensive income (loss).  The fair value of the interest rate swap agreement recorded in accumulated other comprehensive income (loss) may be recognized in the condensed consolidated statement of operations if certain terms of the floating-rate debt change, if the floating-rate debt is extinguished or if the interest rate swap agreement is terminated prior to maturity.  The Company has assessed the creditworthiness of the counterparty of the swap and concludes that no substantial risk of default exists as of December 31, 2014.

ALLOWANCE_FOR_DOUBTFUL_ACCOUNT

ALLOWANCE FOR DOUBTFUL ACCOUNTS:	9 Months Ended
	Dec. 31, 2014
ALLOWANCE FOR DOUBTFUL ACCOUNTS:
ALLOWANCE FOR DOUBTFUL ACCOUNTS:	9.             ALLOWANCE FOR DOUBTFUL ACCOUNTS:
	Trade accounts receivable are presented net of allowances for doubtful accounts, returns and credits of $4.9 million at December 31, 2014 and March 31, 2014.

SEGMENT_INFORMATION

SEGMENT INFORMATION:	9 Months Ended
	Dec. 31, 2014
SEGMENT INFORMATION:
SEGMENT INFORMATION:	10.          SEGMENT INFORMATION:
	The Company reports segment information consistent with the way management internally disaggregates its operations to assess performance and to allocate resources.  We regularly review our segments and the approach used by management to evaluate performance and allocate resources.  Prior to the current fiscal year, the Company’s business segments consisted of Marketing and data services, IT Infrastructure management, and Other services.  The Other services segment consisted solely of the Company’s UK fulfillment business, 2Touch.  On May 30, 2014, the Company substantially completed the sale of 2Touch to Parseq Ltd., a European business process outsourcing service provider (see Note 4 for further details).  As a result, in the current fiscal year, the 2Touch business unit is excluded from segment results and reported as discontinued operations.  The Marketing and data services segment includes the Company’s global lines of business for Customer Data Integration (CDI), Consumer Insight Solutions, Marketing Management Services (including the Audience Operating System and LiveRamp on-boarding services), E-mail Fulfillment Services and Consulting and Agency Services.  The IT Infrastructure management segment develops and delivers IT outsourcing and transformational solutions.
	Company management uses the revenues and income from operations of the remaining two operating segments, among other factors, for performance evaluation and resource allocation.  The Company’s calculation of segment income (loss) from operations does not include inter-company transactions and allocates all corporate expenses, excluding those reported as impairments or gains, losses and other items, as well as certain business separation and transformation expenses.
	The following tables present information by business segment (dollars in thousands):
		For the quarter ended						For the nine months ended
		December 31						December 31
		2014			2013			2014			2013
	Revenue:
	Marketing and data services	$	208,246		$	206,662		$	599,177		$	595,407
	IT Infrastructure management	52,194			62,099			163,515			198,309
	Total revenue	$	260,440		$	268,761		$	762,692		$	793,716
	Income from operations:
	Marketing and data services	$	13,703		$	22,529		$	33,372		$	51,256
	IT Infrastructure management	3,780			6,316			12,649			29,044
	Corporate	(12,291		)	(9,554		)	(42,000		)	(18,324		)
	Income from operations	$	5,192		$	19,291		$	4,021		$	61,976

RESTRUCTURING_IMPAIRMENT_AND_O

RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES:	9 Months Ended
	Dec. 31, 2014
RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES:
RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES:	11.          RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES:
	The Company records costs associated with employee terminations and other exit activity in accordance with applicable accounting standards when those costs become probable and are reasonably estimable.  The following table summarizes the restructuring activity for the nine months ended December 31, 2014 (dollars in thousands):
		Associate-related			Ongoing			Total
		reserves			contract costs
	Continuing operations reserves:
	Balance at March 31, 2014	$	6,542		$	10,217		$	16,759
	Charges and adjustments	6,964			4,625			11,589
	Payments	(8,670		)	(3,204		)	(11,874		)
	Balance at December 31, 2014	$	4,836		$	11,638		$	16,474
	Discontinued operations reserves:
	Charges and adjustments	300			—			300
	Payments	(300		)	—			(300		)
	Balance at December 31, 2014	$	—		$	—		$	—
	The above balances from continuing operations are included in accrued expenses and other liabilities on the condensed consolidated balance sheet.
	Restructuring Plans
	In the nine months ended December 31, 2014, the Company recorded a total of $11.7 million in restructuring charges and adjustments included in gains, losses and other items, net in the condensed consolidated statement of operations.  The expense included severance and other associate-related charges of $7.0 million, lease accruals of $4.6 million, and asset write offs of $0.1 million.
	The associate-related accruals of $7.0 million relate to the termination of associates in the United States, Europe, and China and include an increase of $1.0 million to the fiscal 2014 restructuring plan.  Of the amount accrued for 2015, $3.6 million remained accrued as of December 31, 2014.  These costs are expected to be paid out in fiscal 2015 and 2016.
	The lease accruals of $4.6 million were evaluated under the accounting standards which govern exit costs and include increases of $0.4 million and $0.2 million to the fiscal 2014 and fiscal 2008 restructuring plans, respectively.  These accounting standards require the Company to make an accrual for the liability for lease costs that will continue to be incurred without economic benefit to the Company upon the date that the Company ceases using the leased properties.  The Company has ceased using certain leased office facilities.  The Company intends to attempt to sublease the facilities to the extent possible.  The Company established a liability for the fair value of the remaining lease payments, partially offset by the estimated sublease payments to be received over the course of the leases.  The fair value of these liabilities is based on a net present value model using a credit-adjusted risk-free rate.  The liability will be paid out over the remainder of the leased properties’ terms, which continue through June 2017.  Actual sublease terms may differ from the estimates originally made by the Company.  Any future changes in the estimates or in the actual sublease income could require future adjustments to the liabilities, which would impact net income in the period the adjustment is recorded.  Of the amount accrued for 2015, $2.8 million remained accrued as of December 31, 2014.
	In fiscal 2014, the Company recorded a total of $17.8 million in restructuring charges and adjustments included in gains, losses and other items, net in the consolidated statement of operations.  The expense included severance and other associate-related charges of $14.0 million and lease accruals of $3.8 million.
	The associate-related accruals of $14.0 million relate to the termination of associates in the United States, Australia, China, and Europe.  As noted above, this accrual was increased by $1.0 million in fiscal 2015 as a result of additional associate terminations.  Of the amount accrued, $1.1 million remained accrued as of December 31, 2014.  These costs are expected to be paid out in fiscal 2015 and 2016.
	The lease accruals of $3.8 million were evaluated under the accounting standards which govern exit costs and, as noted above, were increased by $0.4 million in fiscal 2015 from changes in sublease expectations.  These accounting standards require the Company to make an accrual for the liability for lease costs that will continue to be incurred without economic benefit to the Company upon the date that the Company ceases using the leased property.  The Company has ceased using a portion of a certain leased office facility.  The Company intends to attempt to sublease the facility space to the extent possible.  The Company established a liability for the fair value of the remaining lease payments, partially offset by the estimated sublease payments to be received over the course of the lease.  The fair value of this liability is based on a net present value model using a credit-adjusted risk-free rate.  The liability will be paid out over the remainder of the leased property’s term, which continues through November 2021.  Actual sublease terms may differ from the estimates originally made by the Company.  Any future changes in the estimates or in the actual sublease income could require future adjustments to the liability for this lease, which would impact net income in the period the adjustment is recorded.  The remaining amount accrued at December 31, 2014 is $3.3 million.
	As part of its restructuring plans in fiscal 2013, the Company recorded $2.8 million of severance and other associate-related payments in restructuring charges and adjustments included in gains, losses and other items, net in the consolidated statement of operations.  The accruals relate to the termination of associates in the United States, Australia, and Europe.  Of the amount recorded, $0.1 million remained accrued as of December 31, 2014.  These costs are expected to be paid out in fiscal 2015.
	As part of its restructuring plans in fiscal 2012, the Company recorded lease accruals of $2.6 million in restructuring charges and adjustments included in gains, losses and other items, net in the consolidated statement of operations.  The lease accruals were evaluated under the accounting standards which govern exit costs.  These liabilities will be paid out over the remainder of the leased properties’ terms, of which the longest continues through July 2019.  Actual sublease terms may differ from the estimates originally made by the Company.  Any future changes in the estimates or in the actual sublease income could require future adjustments to the liability for these leases, which would impact net income in the period the adjustment is recorded.  The remaining amount accrued at December 31, 2014 is $0.6 million.
	As part of its restructuring plans in fiscal 2008 and 2009, the Company recorded lease accruals included in gains, losses and other items, net in the consolidated statement of operations.  The lease accruals were evaluated under the accounting standards which govern exit costs.  These liabilities will be paid out over the remainder of the leased properties’ terms, of which the longest continues through November 2021.  Any future changes in the estimates or in the actual sublease income could require future adjustments to the liability for these leases, which would impact net income in the period the adjustment is recorded.  The remaining amount accrued at December 31, 2014 is $5.0 million.
	Gains, Losses and Other Items
	Gains, losses and other items for each of the periods presented are as follows (dollars in thousands):
		For the quarter ended						For the nine months ended
		December 31						December 31
		2014			2013			2014			2013
	Restructuring plan charges and adjustments	4,175			3,657			11,736			7,041
	LiveRamp acquisition-related costs	—			—			820			—
	Legal contingencies	—			1,000			—			4,200
		$	4,175		$	4,657		$	12,556		$	11,241

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES:	9 Months Ended
	Dec. 31, 2014
COMMITMENTS AND CONTINGENCIES:
COMMITMENTS AND CONTINGENCIES:	12.          COMMITMENTS AND CONTINGENCIES:
	Legal Matters
	The Company is involved in various claims and legal proceedings. Management routinely assesses the likelihood of adverse judgments or outcomes to these matters, as well as ranges of probable losses, to the extent losses are reasonably estimable. The Company records accruals for these matters to the extent that management concludes a loss is probable and the financial impact, should an adverse outcome occur, is reasonably estimable. These accruals are reflected in the Company’s condensed consolidated financial statements. In management’s opinion, the Company has made appropriate and adequate accruals for these matters and management believes the probability of a material loss beyond the amounts accrued to be remote; however, the ultimate liability for these matters is uncertain, and if accruals are not adequate, an adverse outcome could have a material effect on the Company’s consolidated financial condition or results of operations.  The Company maintains insurance coverage above certain limits.  Listed below is one matter pending against the Company and one of its subsidiaries for which the potential exposure is considered material to the Company’s condensed consolidated financial statements.
	A putative class action is pending against the Company, AISS (which was sold to another company in fiscal 2012), and Acxiom Risk Mitigation, Inc., a Colorado corporation and wholly-owned subsidiary of Acxiom (now known as Acxiom Identity Solutions, LLC), in the United States District Court for the Eastern District of Virginia.  This action seeks to certify nationwide classes of persons who requested a consumer file from any Acxiom entity from 2007 forward; who were the subject of an Acxiom report sold to a third party that contained information not obtained directly from a governmental entity and who did not receive a timely copy of the report; who were the subject of an Acxiom report and about whom Acxiom adjudicated the hire/no hire decision on behalf of the employer; who, from 2010 forward, disputed an Acxiom report and Acxiom did not complete the investigation within 30 days; or who, from 2007 forward,  were the subject of an Acxiom report for which no permissible purpose existed. The complaint alleges various violations of the Fair Credit Reporting Act. The parties have reached a tentative settlement agreement and the Company has accrued $3.7 million as its estimate of its probable loss associated with this matter.  The Company believes the chances of additional loss are remote.
	In the opinion of management, the ultimate disposition of this matter will not have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.
	Commitments
	The Company leases data processing equipment, office furniture and equipment, land and office space under noncancellable operating leases.  The Company has a future commitment for lease payments over the next 26 years of $144.8 million.
	In connection with the disposal of certain assets, the Company guaranteed a lease for the buyer of the assets.  This guarantee was made by the Company primarily to facilitate favorable financing terms for the third party.  Should the third party default, the Company would be required to perform under this guarantee.  At December 31, 2014 the Company’s maximum potential future payments under this guarantee were $1.1 million.

INCOME_TAX

INCOME TAX	9 Months Ended
	Dec. 31, 2014
INCOME TAX:
INCOME TAX	13.          INCOME TAX
	In determining the quarterly provision for income taxes, the Company makes its best estimate of the effective tax rate expected to be applicable for the full fiscal year.  The rate for the current fiscal year is impacted by losses in foreign jurisdictions.  The Company does not record a tax benefit for certain of these losses due to uncertainty of future benefit.  In addition, the quarter ended December 31, 2014 reflects approximately $2.0 million in tax benefit from the retroactive reinstatement of the U.S. research and development tax credit during the quarter.

FINANCIAL_INSTRUMENTS

FINANCIAL INSTRUMENTS:	9 Months Ended
	Dec. 31, 2014
FINANCIAL INSTRUMENTS:
FINANCIAL INSTRUMENTS:	14.          FINANCIAL INSTRUMENTS:
	The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value.
	Cash and cash equivalents, trade receivables, unbilled and notes receivable, short-term borrowings and trade payables - The carrying amount approximates fair value because of the short maturity of these instruments.
	Long-term debt - The interest rate on the term loan and revolving credit agreement is adjusted for changes in market rates and therefore the carrying value of these loans approximates fair value.  The estimated fair value of other long-term debt was determined based upon the present value of the expected cash flows considering expected maturities and using interest rates currently available to the Company for long-term borrowings with similar terms.  At December 31, 2014, the estimated fair value of long-term debt approximates its carrying value.
	Derivative instruments included in other liabilities - The carrying value is adjusted to fair value through other comprehensive income (loss) at each balance sheet date.  The fair value is determined from an interest-rate futures model.
	Under applicable accounting standards financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurements. The Company assigned assets and liabilities to the hierarchy in the accounting standards, which is Level 1 - quoted prices in active markets for identical assets or liabilities, Level 2 - significant other observable inputs and Level 3 - significant unobservable inputs.
	The following table presents the balances of assets and liabilities measured at fair value as of December 31, 2014 (dollars in thousands):
		Level 1		Level 2		Level 3		Total
	Assets:
	Other current assets	$	14,174	$	—	$	—	$	14,174
	Total assets	$	14,174	$	—	$	—	$	14,174
	Liabilities:
	Other accrued expenses	$	—	$	29	$	—	$	29
	Total liabilities	$	—	$	29	$	—	$	29

BASIS_OF_PRESENTATION_AND_SUMM1

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: (Policies)	9 Months Ended
	Dec. 31, 2014
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
Reclassifications	Reclassifications
	Certain amounts reported in previous periods have been reclassified to conform to the current presentation.  On May 30, 2014 the Company substantially completed the sale of its U.K. call center operation, 2Touch, to Parseq Ltd., a European business process outsourcing service provider.  Some assets of the 2Touch operation are subject to a second closing, expected to occur during the current fiscal year.  The 2Touch business qualified for treatment as discontinued operations during the current fiscal year.  The results of operations, cash flows, and the balance sheet amounts pertaining to 2Touch have been classified as discontinued operations in the condensed consolidated financial statements.  Refer to Note 4, Discontinued Operations, for more information regarding the sale.

EARNINGS_LOSS_PER_SHARE_AND_ST1

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY: (Tables)	9 Months Ended
	Dec. 31, 2014
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:
Schedule of reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share	A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share is shown below (in thousands, except per share amounts):
		For the quarter ended						For the nine months ended
		December 31						December 31
		2014			2013			2014			2013
	Basic earnings (loss) per share:
	Net earnings (loss) from continuing operations	$	4,474		$	14,578		$	(3,094	)	$	36,519
	Net earnings (loss) from discontinued operations	(318		)	489			(1,898		)	1,507
	Net earnings (loss)	$	4,156		$	15,067		$	(4,992	)	$	38,026
	Net loss attributable to noncontrolling interest	—			—			—			(60		)
	Net earnings (loss) attributable to Acxiom	$	4,156		$	15,067		$	(4,992	)	$	38,086
	Basic weighted-average shares outstanding	77,039			75,009			76,998			74,155
	Basic earnings (loss) per share:
	Continuing operations	$	0.06		$	0.19		$	(0.04	)	$	0.49
	Discontinued operations	$	—		$	0.01		$	(0.02	)	$	0.02
	Net earnings (loss)	$	0.05		$	0.2		$	(0.06	)	$	0.51
	Net loss attributable to noncontrolling interest	$	—		$	—		$	—		$	—
	Net earnings (loss) attributable to Acxiom	$	0.05		$	0.2		$	(0.06	)	$	0.51
	Diluted earnings (loss) per share:
	Basic weighted-average shares outstanding	77,039			75,009			76,998			74,155
	Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method	1,263			2,830			—			2,301
	Diluted weighted-average shares outstanding	78,302			77,839			76,998			76,456
	Diluted earnings (loss) per share:
	Continuing operations	$	0.06		$	0.19		$	(0.04	)	$	0.48
	Discontinued operations	$	—		$	0.01		$	(0.02	)	$	0.02
	Net earnings (loss)	$	0.05		$	0.19		$	(0.06	)	$	0.5
	Net earnings (loss) attributable to noncontrolling interest	$	—		$	—		$	—		$	—
	Net earnings (loss) attributable to Acxiom	$	0.05		$	0.19		$	(0.06	)	$	0.5
Schedule of antidilutive options, warrants and restricted stock units excluded from computation of earnings (loss) per share	Options and warrants to purchase shares of common stock and restricted stock units that were outstanding during the periods presented, but were not included in the computation of diluted earnings (loss) per share because the effect was antidilutive are shown below (in thousands, except per share amounts):
		For the quarter ended				For the nine months ended
		December 31				December 31
		2014		2013		2014		2013
	Number of shares outstanding under options, warrants and restricted stock units	2,012		549		1,838		1,400
	Range of exercise prices for options and warrants	$18.78-$62.06		$32.85-$62.06		$19.18-$62.06		$21.46-$62.06
Schedule of accumulated balances for each component of other comprehensive income	The accumulated balances for each component of other comprehensive income are as follows (dollars in thousands):
		December 31,			March 31,
		2014			2014
	Foreign currency translation	$	9,393		$	13,686
	Unrealized loss on interest rate swap	(29		)	(24		)
		$	9,364		$	13,662

SHAREBASED_COMPENSATION_Tables

SHARE-BASED COMPENSATION: (Tables)	9 Months Ended
	Dec. 31, 2014
SHARE-BASED COMPENSATION:
Schedule of option activity
		Number		Weighted-average			Weighted-average	Aggregate
		of shares		exercise price			remaining	intrinsic value
				per share			contractual term	(in thousands)
							(in years)
	Outstanding at March 31, 2014	4,538,518		$	20.3
	Granted	415,639		$	21.01
	LiveRamp replacement stock options	1,473,668		$	1.37
	Exercised	(91,200	)	$	6.05			$	1,312
	Forfeited or cancelled	(652,262	)	$	30.54
	Outstanding at December 31, 2014	5,684,363		$	14.49		5.14	$	41,046
	Exercisable at December 31, 2014	3,387,728		$	17.74		3.22	$	15,994
Summary of stock options outstanding and exercisable
		Options outstanding						Options exercisable
	Range of	Options		Weighted- average		Weighted-average		Options		Weighted-average
	exercise price	outstanding		remaining		exercise price		exercisable		exercise price
	per share			contractual life		per share				per share
	$   0.63 - $   8.90	1,411,953		7.54 years		$	1.56	272,262		$	2.09
	$  11.08 - $ 14.42	1,715,499		5.52 years		$	13.22	1,192,268		$	13.10
	$  15.10 - $ 19.76	651,390		2.31 years		$	16.38	617,260		$	16.23
	$  20.44 - $ 25.00	1,571,693		4.61 years		$	22.33	986,775		$	22.95
	$  26.33 - $ 35.16	203,007		1.32 years		$	30.86	188,342		$	30.71
	$  41.38 - $ 62.06	130,821		0.64 years		$	41.83	130,821		$	41.83
		5,684,363		5.14 years		$	14.49	3,387,728		$	17.74
Summary of SAR activity
		Number		Weighted-average			Weighted-average	Aggregate
		of shares		exercise price			remaining	intrinsic value
				per share			contractual term	(in thousands)
							(in years)
	Outstanding at March 31, 2014	—		$	—
	Granted	245,404		$	40.00
	Outstanding at December 31, 2014	245,404		$	40.00		2.25	$	—
	Exercisable at December 31, 2014	—		$	—		—	$	—
Schedule of non-vested time-vesting restricted stock unit activity
		Number		Weighted average			Weighted-average
		of shares		fair value per			remaining contractual
				share at grant			term (in years)
				date
	Outstanding at March 31, 2014	1,078,029		$	18.46		2.17
	Granted	1,650,662		$	21.43
	Vested	(404,428	)	$	17.94
	Forfeited or cancelled	(207,608	)	$	22.02
	Outstanding at December 31, 2014	2,116,655		$	21.59		2.21
Schedule of non-vested performance-based restricted stock unit activity
		Number		Weighted average			Weighted-average
		of shares		fair value per			remaining contractual
				share at grant			term (in years)
				date
	Outstanding at March 31, 2014	1,066,828		$	14.19		0.91
	Granted	259,167		$	18.98
	Vested	(523,378	)	$	9.64
	Forfeited or cancelled	(43,864	)	$	24.87
	Outstanding at December 31, 2014	758,753		$	18.57		1.41
Summary of other performance unit activity
		Number		Weighted average					Weighted-average
		of shares		fair value per					remaining contractual
				share at grant					term (in years)
				date
	Outstanding at March 31, 2014	—			$	—
	Granted	201,464		$		5.18
	Outstanding at December 31, 2014	201,464		$		5.18		2.25

DISCONTINUED_OPERATIONS_Tables

DISCONTINUED OPERATIONS: (Tables)	9 Months Ended
	Dec. 31, 2014
DISCONTINUED OPERATIONS:
Schedule of summary results of operations for discontinued operations	Summary results of operations of the 2Touch business unit for the three and nine months ended December 31, 2014 and 2013, respectively, are segregated and included in earnings (loss) from discontinued operations, net of tax, in the condensed consolidated statements of operations and are as follows (dollars in thousands):
		For the quarter ended					For the nine months ended
		December 31					December 31
		2014			2013		2014			2013
	Revenues	$	1,250		$	9,112	$	8,490		$	26,621
	Earnings (loss) from discontinued operations before income taxes	$	(318	)	$	489	$	(23	)	$	1,507
	Loss on sale of discontinued operations before income taxes	—			—		(1,875		)	—
	Income taxes	—			—		—			—
	Earnings (loss) from discontinued operations, net of tax	$	(318	)	$	489	$	(1,898	)	$	1,507
Schedule of carrying amounts of assets and liabilities of discontinued operations	The carrying amounts of the major classes of assets and liabilities of the 2Touch business unit are segregated and included in assets from discontinued operations and liabilities from discontinued operations in the condensed consolidated balance sheets and are as follows (dollars in thousands):
		December 31,			March 31,
		2014			2014
	Trade accounts receivable, net	$	478		$	6,451
	Other current assets	—			881
	Assets from discontinued operations	$	478		$	7,332
	Trade accounts payable and accrued expenses	$	—		$	4
	Accrued payroll and related expenses	279			1,790
	Other accrued expenses	1,170			2,350
	Deferred revenue	99			106
	Liabilities from discontinued operations	$	1,548		$	4,250

ACQUISITIONS_Tables

ACQUISITIONS: (Tables) (LiveRamp Inc)	9 Months Ended
	Dec. 31, 2014
LiveRamp Inc
Schedule of fair value of consideration transferred
	The acquisition date fair value of the consideration transferred for LiveRamp was approximately $272.7 million which consisted of the following (dollars in thousands):
		July 1, 2014
	Cash, net of $12.0 million cash acquired	$	234,672
	Restricted cash held in escrow	31,000
	Fair value of stock options issued included in purchase price	6,978
	Total fair value of consideration transferred	$	272,650
Schedule of allocation of the purchase prices to assets acquired and liabilities assumed
	The following table summarizes the estimated fair values of assets acquired and liabilities assumed as of the date of the acquisition (dollars in thousands):
		July 1, 2014
	Assets acquired:
	Cash	$	12,016
	Trade accounts receivable	5,206
	Deferred income tax assets	10,444
	Goodwill	215,967
	Developed technology (Software)	40,000
	Other intangible assets (Other assets, net)	26,500
	Other current and noncurrent assets	1,307
		311,440
	Deferred income tax liabilities	(21,820		)
	Accounts payable, accrued expenses and deferred revenue	(4,954		)
	Net assets acquired	284,666
	Less:
	Cash acquired	12,016
	Net purchase price allocated	$	272,650
	Less:
	Fair value of stock options issued included in purchase price	6,978
	Net cash paid	$	265,672
Schedule of finite-lived intangible assets acquired
	The following table presents the components of intangible assets acquired and their estimated useful lives as of the acquisition date (dollars in thousands):
		Fair value			Useful life
					(in years)
	Developed technology	$	40,000		4
	Customer relationship	25,000			6
	Trade name	1,500			2
	Total intangible assets subject to amortization	$	66,500
Condensed consolidated statement of operations information
	The amounts of revenue and loss of LiveRamp included in the Company’s condensed consolidated statement of operations from the acquisition date of July 1, 2014 to December 31, 2014 are as follows (dollars in thousands):
	Revenues	$	15,916
	Net loss	$	(10,022	)
Schedule of pro forma results for LiveRamp as part of the Company	Following are the Company’s supplemental consolidated results on an unaudited pro forma basis, as if the LiveRamp acquisition had taken place at the beginning of each of the fiscal years presented (dollars in thousands):
		For the quarter ended					For the nine months ended
		December 31					December 31
		2014			2013		2014			2013
	Revenues	$	260,440		$	274,276	$	769,400		$	807,156
	Net earnings (loss) attributable to Acxiom	$	4,156		$	10,263	$	(10,363	)	$	23,102
	Diluted earnings per share	$	0.05		$	0.13	$	(0.13	)	$	0.3

OTHER_CURRENT_AND_NONCURRENT_A1

OTHER CURRENT AND NONCURRENT ASSETS: (Tables)	9 Months Ended
	Dec. 31, 2014
OTHER CURRENT AND NONCURRENT ASSETS:
Schedule of other current assets
	Other current assets consist of the following (dollars in thousands):
		December 31,		March 31,
		2014		2014
	Prepaid expenses	$	35,745	$	40,339
	Assets of non-qualified retirement plan	14,174		13,900
	Other miscellaneous assets	244		245
	Other current assets	$	50,163	$	54,484
Schedule of other noncurrent assets	Other noncurrent assets consist of the following (dollars in thousands):
		December 31,		March 31,
		2014		2014
	Acquired intangible assets, net	$	24,164	$	281
	Deferred data acquisition costs	3,211		4,502
	Deferred expenses	10,291		16,143
	Other miscellaneous noncurrent assets	3,591		3,551
	Noncurrent assets	$	41,257	$	24,477

GOODWILL_Tables

GOODWILL: (Tables)	9 Months Ended
	Dec. 31, 2014
GOODWILL:
Schedule of changes in the carrying amount of goodwill by operating segment
	(dollars in thousands)	Marketing and			IT		Total
		Data Services			Infrastructure
					Management
	Balance at March 31, 2014	$	286,876		$	71,508	$	358,384
	LiveRamp acquisition	215,967			—		215,967
	Change in foreign currency translation adjustment	(1,762		)	—		(1,762		)
	Balance at December 31, 2014	$	501,081		$	71,508	$	572,589

LONGTERM_DEBT_Tables

LONG-TERM DEBT: (Tables)	9 Months Ended
	Dec. 31, 2014
LONG-TERM DEBT:
Schedule of long-term debt	Long-term debt consists of the following (dollars in thousands):
		December 31,		March 31,
		2014		2014
	Term loan credit agreement	$	277,500	$	292,500
	Capital leases and installment payment obligations on land, buildings and equipment payable in monthly payments of principal plus interest at rates ranging from approximately 4% to 8%; remaining terms up to eight years	7,975		12,990
	Other debt and long-term liabilities	10,555		12,120
	Total long-term debt and capital leases	296,030		317,610
	Less current installments	33,269		28,567
	Long-term debt, excluding current installments	$	262,761	$	289,043

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION: (Tables)	9 Months Ended
	Dec. 31, 2014
SEGMENT INFORMATION:
Schedule of information by business segment	The following tables present information by business segment (dollars in thousands):
		For the quarter ended						For the nine months ended
		December 31						December 31
		2014			2013			2014			2013
	Revenue:
	Marketing and data services	$	208,246		$	206,662		$	599,177		$	595,407
	IT Infrastructure management	52,194			62,099			163,515			198,309
	Total revenue	$	260,440		$	268,761		$	762,692		$	793,716
	Income from operations:
	Marketing and data services	$	13,703		$	22,529		$	33,372		$	51,256
	IT Infrastructure management	3,780			6,316			12,649			29,044
	Corporate	(12,291		)	(9,554		)	(42,000		)	(18,324		)
	Income from operations	$	5,192		$	19,291		$	4,021		$	61,976

RESTRUCTURING_IMPAIRMENT_AND_O1

RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES: (Tables)	9 Months Ended
	Dec. 31, 2014
RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES:
Summary of the restructuring activity	The following table summarizes the restructuring activity for the nine months ended December 31, 2014 (dollars in thousands):
		Associate-related			Ongoing			Total
		reserves			contract costs
	Continuing operations reserves:
	Balance at March 31, 2014	$	6,542		$	10,217		$	16,759
	Charges and adjustments	6,964			4,625			11,589
	Payments	(8,670		)	(3,204		)	(11,874		)
	Balance at December 31, 2014	$	4,836		$	11,638		$	16,474
	Discontinued operations reserves:
	Charges and adjustments	300			—			300
	Payments	(300		)	—			(300		)
	Balance at December 31, 2014	$	—		$	—		$	—
Schedule of gains, losses and other items	Gains, losses and other items for each of the periods presented are as follows (dollars in thousands):
		For the quarter ended						For the nine months ended
		December 31						December 31
		2014			2013			2014			2013
	Restructuring plan charges and adjustments	4,175			3,657			11,736			7,041
	LiveRamp acquisition-related costs	—			—			820			—
	Legal contingencies	—			1,000			—			4,200
		$	4,175		$	4,657		$	12,556		$	11,241

FINANCIAL_INSTRUMENTS_Tables

FINANCIAL INSTRUMENTS: (Tables)	9 Months Ended
	Dec. 31, 2014
FINANCIAL INSTRUMENTS:
Schedule of assets and liabilities measured at fair value	The following table presents the balances of assets and liabilities measured at fair value as of December 31, 2014 (dollars in thousands):
		Level 1		Level 2		Level 3		Total
	Assets:
	Other current assets	$	14,174	$	—	$	—	$	14,174
	Total assets	$	14,174	$	—	$	—	$	14,174
	Liabilities:
	Other accrued expenses	$	—	$	29	$	—	$	29
	Total liabilities	$	—	$	29	$	—	$	29

EARNINGS_LOSS_PER_SHARE_AND_ST2

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY: (Details) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Aug. 31, 2011
Stockholders' Equity
Maximum amount of common stock that may be repurchased						$250,000,000
Shares repurchased			500,000
Repurchase of treasury stock			9,868,000	52,663,000
Cumulative amount paid for repurchase of treasury stock	945,213,000		945,213,000		928,203,000
Remaining capacity under the stock repurchase program	47,600,000		47,600,000
Basic earnings (loss) per share:
Net earnings (loss) from continuing operations	4,474,000	14,578,000	-3,094,000	36,519,000
Net earnings (loss) from discontinued operations	-318,000	489,000	-1,898,000	1,507,000
Net earnings (loss)	4,156,000	15,067,000	-4,992,000	38,026,000
Net loss attributable to noncontrolling interest				-60,000
Net earnings (loss) attributable to Acxiom	4,156,000	15,067,000	-4,992,000	38,086,000
Basic weighted-average shares outstanding	77,039,000	75,009,000	76,998,000	74,155,000
Net earnings (loss) from continuing operations (in dollars per share)	$0.06	$0.19	($0.04)	$0.49
Net earnings (loss) from discontinued operations (in dollars per share)		$0.01	($0.02)	$0.02
Net earnings (loss) (in dollars per share)	$0.05	$0.20	($0.06)	$0.51
Net earnings (loss) attributable to Acxiom (in dollars per share)	$0.05	$0.20	($0.06)	$0.51
Diluted earnings (loss) per share:
Basic weighted-average shares outstanding	77,039,000	75,009,000	76,998,000	74,155,000
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method (in shares)	1,263,000	2,830,000		2,301,000
Diluted weighted-average shares outstanding	78,302,000	77,839,000	76,998,000	76,456,000
Net earnings (loss) from continuing operations (in dollars per share)	$0.06	$0.19	($0.04)	$0.48
Net earnings (loss) from discontinued operations (in dollars per share)		$0.01	($0.02)	$0.02
Net earnings (loss) (in dollars per share)	$0.05	$0.19	($0.06)	$0.50
Net earnings (loss) attributable to Acxiom (in dollars per share)	$0.05	$0.19	($0.06)	$0.50
Stockholders' Equity
Number of shares outstanding under options, warrants and restricted stock units	2,012,000	549,000	1,838,000	1,400,000
Minimum
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:
Range of exercise prices for options and warrants (in dollars per share)	$18.78	$32.85	$19.18	$21.46
Maximum
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:
Range of exercise prices for options and warrants (in dollars per share)	$62.06	$62.06	$62.06	$62.06
2011 Common stock repurchase program
Stockholders' Equity
Cumulative shares repurchased	12,900,000		12,900,000
Cumulative amount paid for repurchase of treasury stock	$202,400,000		$202,400,000

EARNINGS_LOSS_PER_SHARE_AND_ST3

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY (Detail 2) (USD $)	Dec. 31, 2014	Mar. 31, 2014
In Thousands, unless otherwise specified
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:
Foreign currency translation	$9,393	$13,686
Unrealized loss on interest rate swap	-29	-24
Accumulated Other Comprehensive Income	$9,364	$13,662

EARNINGS_LOSS_PER_SHARE_AND_ST4

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY: (Details 3) (GoDigital)	Mar. 31, 2011
GoDigital
Noncontrolling Interest
Percentage of interest acquired	70.00%

SHAREBASED_COMPENSATION_Detail

SHARE-BASED COMPENSATION: (Details) (USD $)	9 Months Ended	0 Months Ended
	Dec. 31, 2014	Jul. 01, 2014
Option Activity - Number of Shares
Outstanding at the beginning of the period (in shares)	4,538,518
Granted (in shares)	415,639
LiveRamp replacement stock options	1,473,668
Exercised (in shares)	-91,200
Forfeited or cancelled (in shares)	-652,262
Outstanding at the end of the period (in shares)	5,684,363
Exercisable at the end of the period (in shares)	3,387,728
Weighted-average exercise price per share
Outstanding at the beginning of the period (in dollars per share)	$20.30
Granted (in dollars per share)	$21.01
LiveRamp replacement stock options (in dollars per share)	$1.37
Exercised (in dollars per share)	$6.05
Forfeited or cancelled (in dollars per share)	$30.54
Outstanding at the end of the period (in dollars per share)	$14.49
Exercisable at the end of the period (in dollars per share)	$17.74
Weighted-average remaining contractual term
Outstanding at the end of the period	5 years 1 month 21 days
Exercisable at the end of the period	3 years 2 months 19 days
Aggregate intrinsic value
Exercised	$1,312,000
Outstanding at the end of the period	41,046,000
Exercisable at the end of the period	15,994,000
Stock Option and Equity Compensation Plans
Share-based compensation
Aggregate number of shares reserved for issuance under equity compensation plans since the inception of such plans	26,400,000
Shares which remained available for future grants	2,600,000
Stock options
Share-based compensation
Granted (in shares)	415,639
Per-share weighted-average fair value of the stock options granted (in dollars per share)	$8.05
Pricing model used for share-based compensation arrangement	binomial lattice
Dividend yield (as a percent)	0.00%
Risk-free interest rate (as a percent)	0.03%
Expected option life	4 years 4 months 24 days
Expected volatility (as a percent)	0.43%
Suboptimal exercise multiple	1.4
LiveRamp Inc
Share-based compensation
Fair value of stock options included in purchase price		6,978,000
Stock options assumed allocated to future services		23,500,000
LiveRamp Inc | Stock options
Share-based compensation
Pricing model used for share-based compensation arrangement	binomial lattice
Dividend yield (as a percent)	0.00%
Minimum risk-free interest rate (as a percent)	0.02%
Maximum risk-free interest rate (as a percent)	0.03%
Expected volatility (as a percent)	0.43%
Suboptimal exercise multiple	1.4
Stock options assumed allocated to future services	$23,500,000
LiveRamp stock option exchange ratio	0.64%
Maximum | LiveRamp Inc | Stock options
Share-based compensation
Expected option life	9 years 8 months 12 days
Minimum | LiveRamp Inc | Stock options
Share-based compensation
Expected option life	6 years 1 month 6 days

SHAREBASED_COMPENSATION_Detail1

SHARE-BASED COMPENSATION: (Details 2) (USD $)	9 Months Ended
	Dec. 31, 2014
Stock options outstanding and exercisable by exercise price range
Options outstanding (in shares)	5,684,363
Options outstanding - Weighted-average remaining contractual life	5 years 1 month 21 days
Options outstanding - Weighted-average exercise price per share (in dollars per share)	$14.49
Options exercisable (in shares)	3,387,728
Options exercisable - Weighted-average exercise price per share (in dollars per share)	$17.74
Range of exercise price per share from $0.63 to $8.90
Stock options outstanding and exercisable by exercise price range
Exercise price per share, low end of range (in dollars per share)	$0.63
Exercise price per share, high end of range (in dollars per share)	$8.90
Options outstanding (in shares)	1,411,953
Options outstanding - Weighted-average remaining contractual life	7 years 6 months 15 days
Options outstanding - Weighted-average exercise price per share (in dollars per share)	$1.56
Options exercisable (in shares)	272,262
Options exercisable - Weighted-average exercise price per share (in dollars per share)	$2.09
Range of exercise price per share from $11.08 to $14.42
Stock options outstanding and exercisable by exercise price range
Exercise price per share, low end of range (in dollars per share)	$11.08
Exercise price per share, high end of range (in dollars per share)	$14.42
Options outstanding (in shares)	1,715,499
Options outstanding - Weighted-average remaining contractual life	5 years 6 months 7 days
Options outstanding - Weighted-average exercise price per share (in dollars per share)	$13.22
Options exercisable (in shares)	1,192,268
Options exercisable - Weighted-average exercise price per share (in dollars per share)	$13.10
Range of exercise price per share from $15.10 to $19.76
Stock options outstanding and exercisable by exercise price range
Exercise price per share, low end of range (in dollars per share)	$15.10
Exercise price per share, high end of range (in dollars per share)	$19.76
Options outstanding (in shares)	651,390
Options outstanding - Weighted-average remaining contractual life	2 years 3 months 22 days
Options outstanding - Weighted-average exercise price per share (in dollars per share)	$16.38
Options exercisable (in shares)	617,260
Options exercisable - Weighted-average exercise price per share (in dollars per share)	$16.23
Range of exercise price per share from $20.44 to $25.00
Stock options outstanding and exercisable by exercise price range
Exercise price per share, low end of range (in dollars per share)	$20.44
Exercise price per share, high end of range (in dollars per share)	$25
Options outstanding (in shares)	1,571,693
Options outstanding - Weighted-average remaining contractual life	4 years 7 months 10 days
Options outstanding - Weighted-average exercise price per share (in dollars per share)	$22.33
Options exercisable (in shares)	986,775
Options exercisable - Weighted-average exercise price per share (in dollars per share)	$22.95
Range of exercise price per share from $26.33 to $35.16
Stock options outstanding and exercisable by exercise price range
Exercise price per share, low end of range (in dollars per share)	$26.33
Exercise price per share, high end of range (in dollars per share)	$35.16
Options outstanding (in shares)	203,007
Options outstanding - Weighted-average remaining contractual life	1 year 3 months 26 days
Options outstanding - Weighted-average exercise price per share (in dollars per share)	$30.86
Options exercisable (in shares)	188,342
Options exercisable - Weighted-average exercise price per share (in dollars per share)	$30.71
Range of exercise price per share from $41.38 to $62.06
Stock options outstanding and exercisable by exercise price range
Exercise price per share, low end of range (in dollars per share)	$41.38
Exercise price per share, high end of range (in dollars per share)	$62.06
Options outstanding (in shares)	130,821
Options outstanding - Weighted-average remaining contractual life	7 months 21 days
Options outstanding - Weighted-average exercise price per share (in dollars per share)	$41.83
Options exercisable (in shares)	130,821
Options exercisable - Weighted-average exercise price per share (in dollars per share)	$41.83

SHAREBASED_COMPENSATION_Detail2

SHARE-BASED COMPENSATION: (Details 3) (USD $)	9 Months Ended		12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2014
Non-vested restricted stock unit activity
Outstanding at the end of the period (in shares)	245,404
Non-vested restricted stock units, Weighted average fair value per share at grant date
Outstanding at the end of the period (in dollars per share)	$40
Weighted-average remaining contractual term
Weighted-average remaining contractual term at the beginning of the period	2 years 3 months
Weighted-average remaining contractual term at the end of the period	2 years 3 months
Restricted Stock Unit Activity - Other disclosures
Aggregate fair value of restricted stock units granted	$1
Minimum
Restricted Stock Unit Activity - Other disclosures
Performance share awards vested (as a percent)	0.00%
Maximum
Restricted Stock Unit Activity - Other disclosures
Performance share awards vested (as a percent)	100.00%
Performance-based
Share-based compensation
Share-based compensation expense	0.2
Future share-based compensation expense expected	0.8
Period for recognition of unrecognized stock-based compensation expense	3 years
Non-vested restricted stock unit activity
Granted (in shares)	201,464
Outstanding at the end of the period (in shares)	201,464
Non-vested restricted stock units, Weighted average fair value per share at grant date
Granted (in dollars per share)	$5.18
Outstanding at the end of the period (in dollars per share)	$5.18
Weighted-average remaining contractual term
Weighted-average remaining contractual term at the beginning of the period	2 years 3 months
Weighted-average remaining contractual term at the end of the period	2 years 3 months
Restricted Stock Unit Activity - Other disclosures
Performance share awards vested (as a percent)	100.00%
Consecutive trading days during the performance period	20 days
Performance-based | Minimum
Restricted Stock Unit Activity - Other disclosures
Price (in dollars per share)	$40
Performance-based | Maximum
Restricted Stock Unit Activity - Other disclosures
Price (in dollars per share)	$70
Restricted stock units
Share-based compensation
Share-based compensation expense	12.8	8.6
Future share-based compensation expense expected	39.5
Period for recognition of unrecognized stock-based compensation expense	4 years
Restricted stock units | Time-vesting
Non-vested restricted stock unit activity
Outstanding at the beginning of the period (in shares)	1,078,029
Granted (in shares)	1,650,662
Vested (in shares)	-404,428
Forfeited or cancelled (in shares)	-207,608
Outstanding at the end of the period (in shares)	2,116,655		1,078,029
Non-vested restricted stock units, Weighted average fair value per share at grant date
Outstanding at the beginning of the period (in dollars per share)	$18.46
Granted (in dollars per share)	$21.43
Vested (in dollars per share)	$17.94
Forfeited or cancelled (in dollars per share)	$22.02
Outstanding at the end of the period (in dollars per share)	$21.59		$18.46
Weighted-average remaining contractual term
Weighted-average remaining contractual term at the beginning of the period	2 years 2 months 16 days		2 years 2 months 1 day
Weighted-average remaining contractual term at the end of the period	2 years 2 months 16 days		2 years 2 months 1 day
Restricted Stock Unit Activity - Other disclosures
Aggregate fair value of restricted stock units granted	35.4
Restricted stock units | Vesting in equal annual increments over four years
Non-vested restricted stock unit activity
Granted (in shares)	673,482
Restricted Stock Unit Activity - Other disclosures
Award vesting period	4 years
Restricted stock units | Vesting in equal annual increments over two years
Non-vested restricted stock unit activity
Granted (in shares)	928,252
Restricted Stock Unit Activity - Other disclosures
Award vesting period	2 years
Restricted stock units | Vesting in one year
Non-vested restricted stock unit activity
Granted (in shares)	48,928
Restricted Stock Unit Activity - Other disclosures
Award vesting period	1 year
Restricted stock units | Performance-based
Non-vested restricted stock unit activity
Outstanding at the beginning of the period (in shares)	1,066,828
Granted (in shares)	259,167
Vested (in shares)	-523,378
Forfeited or cancelled (in shares)	-43,864
Outstanding at the end of the period (in shares)	758,753		1,066,828
Non-vested restricted stock units, Weighted average fair value per share at grant date
Outstanding at the beginning of the period (in dollars per share)	$14.19
Granted (in dollars per share)	$18.98
Vested (in dollars per share)	$9.64
Forfeited or cancelled (in dollars per share)	$24.87
Outstanding at the end of the period (in dollars per share)	$18.57		$14.19
Weighted-average remaining contractual term
Weighted-average remaining contractual term at the beginning of the period	1 year 4 months 28 days		10 months 28 days
Weighted-average remaining contractual term at the end of the period	1 year 4 months 28 days		10 months 28 days
Restricted Stock Unit Activity - Other disclosures
Aggregate fair value of restricted stock units granted	4.9
Restricted stock units | Vesting based on total shareholder return | Minimum
Restricted Stock Unit Activity - Other disclosures
Performance share awards vested (as a percent)	0.00%
Restricted stock units | Vesting based on total shareholder return | Maximum
Restricted Stock Unit Activity - Other disclosures
Performance share awards vested (as a percent)	200.00%
Stock options
Share-based compensation
Share-based compensation expense	7	1.7
Future share-based compensation expense expected	23.7
Period for recognition of unrecognized stock-based compensation expense	4 years
Restricted Stock Unit Activity - Other disclosures
Pricing model used for share-based compensation arrangement	binomial lattice
Stock Appreciation Rights (SARs) | Performance-based
Share-based compensation
Share-based compensation expense	0.1
Future share-based compensation expense expected	0.4
Period for recognition of unrecognized stock-based compensation expense	3 years
Non-vested restricted stock unit activity
Granted (in shares)	245,404
Non-vested restricted stock units, Weighted average fair value per share at grant date
Granted (in dollars per share)	$40
Restricted Stock Unit Activity - Other disclosures
Aggregate fair value of restricted stock units granted	0.5
Exercise price	$40
Price (in dollars per share)	$70
Consecutive trading days during the performance period	20 days
LiveRamp Inc
Restricted Stock Unit Activity - Other disclosures
Aggregate fair value of restricted stock units granted	$23.70
LiveRamp Inc | Restricted stock units | Time-vesting
Non-vested restricted stock unit activity
Granted (in shares)	1,075,392
LiveRamp Inc | Stock options
Restricted Stock Unit Activity - Other disclosures
Pricing model used for share-based compensation arrangement	binomial lattice

DISCONTINUED_OPERATIONS_Detail

DISCONTINUED OPERATIONS: (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2014
Earnings from discontinued operations
Income from discontinued operations, net of tax			($1,898)	$1,507
Carrying amounts of the major classes of assets and liabilities
Goodwill	572,589		572,589		358,384
Assets from discontinued operations	478		478		7,332
Liabilities from discontinued operations	1,548		1,548		4,250
United Kingdom Call Center Operation 2 Touch
DIVESTITURES
Revenue associated with discontinued operations	1,250	9,112	8,490	26,621
Earnings from discontinued operations
Earnings (loss) from discontinued operations before income taxes	-318	489	-23	1,507
Gain on sale of discontinued operations before income taxes			-1,875
Income from discontinued operations, net of tax	-318	489	-1,898	1,507
Carrying amounts of the major classes of assets and liabilities
Trade accounts receivable, net	478		478		6,451
Other current assets					881
Assets from discontinued operations	478		478		7,332
Trade accounts payable and accrued expenses					4
Accrued payroll and related expenses	279		279		1,790
Other accrued expenses	1,170		1,170		2,350
Deferred revenue	99		99		106
Liabilities from discontinued operations	$1,548		$1,548		$4,250

ACQUISITIONS_Details

ACQUISITIONS: (Details) (USD $)	0 Months Ended	9 Months Ended
	Jul. 01, 2014	Dec. 31, 2014	Mar. 31, 2014
Fair value of consideration
Contractual term for settlement of purchase escrow	1 year
Purchase price allocation
Goodwill		$572,589,000	$358,384,000
Less:
Net cash paid		265,672,000
LiveRamp Inc
Fair value of consideration
Cash, net of $12.0 million cash acquired	234,672,000
Restricted cash held in escrow	31,000,000
Fair value of stock options included in purchase price	6,978,000
Total fair value of consideration transferred	272,650,000
Stock options assumed
Total fair value of stock options assumed, including amounts allocated to future services	30,500,000
Fair value of stock options allocated to the purchase consideration	6,978,000
Stock options assumed allocated to future services	23,500,000
Purchase price allocation
Cash	12,016,000
Trade accounts receivable	5,206,000
Deferred income tax assets	10,444,000
Goodwill	215,967,000
Other intangible assets	66,500,000
Other current and noncurrent assets	1,307,000
Total assets	311,440,000
Deferred income tax liabilities	21,820,000
Accounts payable, accrued expenses and deferred revenue	4,954,000
Net assets acquired	284,666,000
Less:
Cash Acquired from Acquisition	12,016,000
Net purchase price allocated	272,650,000
Fair value of stock options included in purchase price	6,978,000
Net cash paid	265,672,000
Receivables
Gross accounts receivable	5,000,000
Unbilled Receivables, Current	200,000
LiveRamp Inc | Maximum
Purchase price allocation
Amortization lives for intangibles	6 years
LiveRamp Inc | Minimum
Purchase price allocation
Amortization lives for intangibles	2 years
LiveRamp Inc | Developed technology
Purchase price allocation
Other intangible assets	40,000,000
Amortization lives for intangibles	4 years
LiveRamp Inc | Other intangible assets
Purchase price allocation
Other intangible assets	26,500,000
LiveRamp Inc | Customer relationship
Purchase price allocation
Other intangible assets	25,000,000
Amortization lives for intangibles	6 years
LiveRamp Inc | Trade name
Purchase price allocation
Other intangible assets	1,500,000
Amortization lives for intangibles	2 years

ACQUISITIONS_Details_2

ACQUISITIONS (Details 2) (USD $)	3 Months Ended			6 Months Ended	9 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenues	$260,440,000		$268,761,000		$762,692,000	$793,716,000
Net loss	4,156,000		15,067,000		-4,992,000	38,026,000
Share-based Compensation					20,538,000	10,344,000
LiveRamp Inc
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenues				15,916,000
Net loss				-10,022,000
Amortization of Intangible Assets	3,700,000	3,700,000		7,500,000
Share-based Compensation	4,800,000	4,800,000		9,900,000
Pro Forma Information
Revenues	260,440,000		274,276,000		769,400,000	807,156,000
Net earnings (loss) attributable to Acxiom	4,156,000		10,263,000		-10,363,000	23,102,000
Diluted earnings per share	$0.05		$0.13		($0.13)	$0.30
Acquisition information
Transaction fees related to the acquisition					$800,000

OTHER_CURRENT_AND_NONCURRENT_A2

OTHER CURRENT AND NONCURRENT ASSETS: (Details) (USD $)	Dec. 31, 2014	Mar. 31, 2014
In Thousands, unless otherwise specified
Other current assets
Prepaid expenses	$35,745	$40,339
Assets of non-qualified retirement plan	14,174	13,900
Other miscellaneous assets	244	245
Total other current assets	50,163	54,484
Other noncurrent assets
Acquired intangible assets, net	24,164	281
Deferred data acquisitions costs	3,211	4,502
Deferred costs	10,291	16,143
Other miscellaneous noncurrent assets	3,591	3,551
Noncurrent assets	41,257	24,477
LiveRamp Inc | Other intangible assets
Other noncurrent assets
Acquired intangible assets, net	$24,000

GOODWILL_Details

GOODWILL: (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Mar. 31, 2014
Goodwill
Goodwill at the beginning of the period	$358,384
LiveRamp acquisition	215,967
Change in foreign currency translation adjustment	-1,762
Goodwill at the end of the period	572,589
Marketing and Data Services
Goodwill
Goodwill at the beginning of the period	286,876
LiveRamp acquisition	215,967
Change in foreign currency translation adjustment	-1,762
Goodwill at the end of the period	501,081
Marketing and Data Services | United States
Goodwill
Goodwill at the end of the period	482,700
Marketing and Data Services | Australia
Goodwill
Goodwill at the end of the period	11,600
Marketing and Data Services | China
Goodwill
Goodwill at the end of the period	6,000
Marketing and Data Services | Brazil
Goodwill
Goodwill at the end of the period	800
IT Infrastructure Management
Goodwill
Goodwill at the beginning of the period		71,508
Goodwill at the end of the period	$71,508	$71,508

GOODWILL_Details_2

GOODWILL: (Details 2) (USD $)	0 Months Ended
In Thousands, unless otherwise specified	Apr. 01, 2014	Dec. 31, 2014	Apr. 01, 2014	Mar. 31, 2014
	component
Goodwill information
Number of components tested for impairment	5
Goodwill		$572,589		$358,384
Fair values in excess of the carrying value (as a percent)	35.00%		35.00%
U.S. Marketing and Data Services
Goodwill information
Goodwill	266,700		266,700
Australia Marketing and Data Services
Goodwill information
Goodwill	13,300		13,300
China Marketing and Data Services
Goodwill information
Goodwill	6,000		6,000
Brazil Marketing and Data Services
Goodwill information
Goodwill	900		900
U.S. Infrastructure Management
Goodwill information
Goodwill	$71,500		71,500

LONGTERM_DEBT_Details

LONG-TERM DEBT: (Details) (USD $)	9 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Mar. 10, 2014
Long-term debt
Total long-term debt and capital leases	$296,030,000		$317,610,000
Less current installments	33,269,000		28,567,000
Long-term debt, excluding current installments	262,761,000		289,043,000
Existing debt repaid with proceeds of term loan	19,815,000	230,167,000
Weighted-average interest rate on long-term debt (as a percent)	2.30%
Outstanding letters of credit	2,200,000
LIBOR rate (as a percent)	0.25%
Interest rate swap | March 10, 2014 derivative agreement | Cash flow hedge
Long-term debt
Fixed interest rate payable on swap (as a percent)				0.98%
Notional amount of derivative				50,000,000
Fair market value of the derivative	0
Unrealized loss of the derivative recorded in other comprehensive income (loss)	30,000
LIBOR | Interest rate swap | March 10, 2014 derivative agreement
Long-term debt
Long-term debt variable interest rate description	LIBOR
Term loan credit agreement
Long-term debt
Total long-term debt and capital leases	277,500,000		292,500,000
Aggregate amount of borrowing commitment	300,000,000
Term loan credit agreement | Quarterly installments payable through September 2017
Long-term debt
Required quarterly installment payments	7,500,000
Term loan credit agreement | Quarterly installments payable through June 2018
Long-term debt
Required quarterly installment payments	11,300,000
Term loan credit agreement | Final payment due on October 9, 2018
Long-term debt
Final payment of long-term debt	161,300,000
Term loan credit agreement | LIBOR
Long-term debt
Long-term debt basis spread on variable interest rate (as a percent)	2.00%
Capital leases and installment payment obligations
Long-term debt
Total long-term debt and capital leases	7,975,000		12,990,000
Long-term debt stated interest rate percentage, minimum	4.00%
Long-term debt stated interest rate percentage, maximum	8.00%
Maximum remaining maturity period of debt	8 years
Other debt and long-term liabilities
Long-term debt
Total long-term debt and capital leases	10,555,000		12,120,000
Revolving credit facility
Long-term debt
Aggregate amount of borrowing commitment	300,000,000
Outstanding revolving credit borrowings	0
Revolving credit facility dividend restrictions amount, maximum	$30,000,000
Revolving credit facility | LIBOR
Long-term debt
Long-term debt basis spread on variable interest rate (as a percent)	2.00%

ALLOWANCE_FOR_DOUBTFUL_ACCOUNT1

ALLOWANCE FOR DOUBTFUL ACCOUNTS: (Details) (Allowance for doubtful accounts, returns and credits, USD $)	Dec. 31, 2014	Mar. 31, 2014
In Millions, unless otherwise specified
Allowance for doubtful accounts, returns and credits
Allowance for doubtful accounts, returns and credits
Balance at beginning of period	$4.90	$4.90
Balance at end of period	$4.90	$4.90

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION: (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
			segment
Information by business segment
Number of operating segments			2
Revenue:
Total revenue	$260,440	$268,761	$762,692	$793,716
Income from operations:
Income from operations	5,192	19,291	4,021	61,976
Operating segment
Revenue:
Total revenue	260,440	268,761	762,692	793,716
Operating segment | Marketing and Data Services
Revenue:
Total revenue	208,246	206,662	599,177	595,407
Income from operations:
Income from operations	13,703	22,529	33,372	51,256
Operating segment | IT Infrastructure Management
Revenue:
Total revenue	52,194	62,099	163,515	198,309
Income from operations:
Income from operations	3,780	6,316	12,649	29,044
Corporate
Income from operations:
Income from operations	($12,291)	($9,554)	($42,000)	($18,324)

RESTRUCTURING_IMPAIRMENT_AND_O2

RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES: (Details) (USD $)	9 Months Ended	12 Months Ended
	Dec. 31, 2014	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Continuing operations
Restructuring activity
Balance at the beginning of the period	$16,759,000
Charges and adjustments	11,589,000
Payments	-11,874,000
Balance at the end of the period	16,474,000
Discontinued operations
Restructuring activity
Charges and adjustments	300,000
Payments	-300,000
Fiscal 2015
Restructuring activity
Restructuring charges	11,700,000
Fiscal 2014
Restructuring activity
Charges and adjustments	11,700,000	17,800,000
Associate-related reserves | Continuing operations
Restructuring activity
Balance at the beginning of the period	6,542,000
Charges and adjustments	6,964,000
Payments	-8,670,000
Balance at the end of the period	4,836,000
Associate-related reserves | Discontinued operations
Restructuring activity
Charges and adjustments	300,000
Payments	-300,000
Associate-related reserves | United States, Australia, China and Europe
Restructuring activity
Charges and adjustments	1,000,000
Associate-related reserves | Fiscal 2015
Restructuring activity
Charges and adjustments	7,000,000
Associate-related reserves | Fiscal 2015 | United States And Europe
Restructuring activity
Charges and adjustments	7,000,000
Balance at the end of the period	3,600,000
Associate-related reserves | Fiscal 2014
Restructuring activity
Charges and adjustments		14,000,000
Associate-related reserves | Fiscal 2014 | United States, Australia, China and Europe
Restructuring activity
Charges and adjustments	1,000,000
Associate-related reserves | Fiscal 2014 | United States, Australia, and Europe
Restructuring activity
Charges and adjustments		14,000,000
Balance at the end of the period	1,100,000
Associate-related reserves | Fiscal 2013 | United States, Australia, and Europe
Restructuring activity
Charges and adjustments			2,800,000
Balance at the end of the period	100,000
Ongoing contract costs | Continuing operations
Restructuring activity
Balance at the beginning of the period	10,217,000
Charges and adjustments	4,625,000
Payments	-3,204,000
Balance at the end of the period	11,638,000
Ongoing contract costs | Fiscal 2015
Restructuring activity
Charges and adjustments	4,600,000
Balance at the end of the period	2,800,000
Ongoing contract costs | Fiscal 2014
Restructuring activity
Charges and adjustments	400,000	3,800,000
Balance at the end of the period	3,300,000
Ongoing contract costs | Fiscal 2012
Restructuring activity
Charges and adjustments				2,600,000
Balance at the end of the period	600,000
Ongoing contract costs | Fiscal 2008 and 2009
Restructuring activity
Balance at the end of the period	5,000,000
Ongoing contract costs | Fiscal 2008
Restructuring activity
Charges and adjustments	200,000
Facility Closing | Fiscal 2014
Restructuring activity
Charges and adjustments	$100,000

RESTRUCTURING_IMPAIRMENT_AND_O3

RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES: (Details 2) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Gains, Losses and Other Items
Restructuring plan charges and adjustments	$4,175	$3,657	$11,736	$7,041
LiveRamp acquisition-related costs			820
Legal contingencies		1,000		4,200
Gains, losses and other items	$4,175	$4,657	$12,556	$11,241

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES: (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Mar. 31, 2011
Operating lease and licensing agreements
Commitments
Future commitment for lease payments under noncancellable operating leases	26 years
Future commitment for lease payments under noncancellable operating leases	$144.80
GoDigital
Commitments
Percentage of interest acquired		70.00%
Pending legal matters
Commitments
Period of dispute investigation	30 days
Accrual for gains, losses and other expenses	$3.70

COMMITMENTS_AND_CONTINGENCIES_1

COMMITMENTS AND CONTINGENCIES: (Details 2) (Loan guarantees, USD $)	Dec. 31, 2014
In Millions, unless otherwise specified
Loan guarantees
Commitments
Maximum potential future payments under guarantees of third-party indebtedness	$1.10

INCOME_TAX_Details

INCOME TAX: (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
INCOME TAX:
Income taxes	($1,926)	$3,083	($1,023)	$17,582

FINANCIAL_INSTRUMENTS_Details

FINANCIAL INSTRUMENTS: (Details) (USD $)	Dec. 31, 2014	Mar. 31, 2014
In Thousands, unless otherwise specified
Assets:
Other current assets	$50,163	$54,484
Fair value measurements on recurring basis | Level 1
Assets:
Other current assets	14,174
Total assets	14,174
Fair value measurements on recurring basis | Level 2
Liabilities:
Other accrued expenses	29
Total liabilities	29
Fair value measurements on recurring basis | Total
Assets:
Other current assets	14,174
Total assets	14,174
Liabilities:
Other accrued expenses	29
Total liabilities	$29